syndrome	score	normalized_score
DRAVET SYNDROME	2.6781298399999995	100.0
CHILDHOOD ABSENCE EPILEPSY	1.52074085	56.783686410065926
MYOCLONIC-ASTASTIC EPILEPSY	1.2308145400000001	45.95798611466875
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.57192411552384
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1564266	43.18037843900803
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.339489111551075
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.339489111551075
MYOCLONIC EPILEPSY OF LAFORA	0.93909192	35.06521252158559
LAFORA DISEASE	0.7746924	28.926618434601366
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.774448814625064
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7480334099999999	27.931185367771416
EARLY MYOCLONIC ENCEPHALOPATHY	0.7128345199999999	26.61687679787773
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.6955347199999999	25.97091110414572
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.60217849	22.485037170565267
ROLANDIC EPILEPSY	0.5906213	22.053497600400142
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5636522	21.04648518460181
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5348101000000001	19.969535905697544
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.67891892799343
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.52245151	19.508072468958417
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5150467	19.23158064659031
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.932698572971358
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.50168634	18.73271162984391
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.500541419	18.689960864630827
CREST SYNDROME	0.5	18.669744555775537
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5	18.669744555775537
INHALATIONAL ANTHRAX	0.5	18.669744555775537
PAROXYSMAL HEMICRANIA	0.5	18.669744555775537
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.669744555775537
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.669744555775537
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42673753000000003	15.9341613549252
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41923690999999996	15.654092036105316
SPINOCEREBELLAR ATAXIA TYPE 10	0.41057764	15.330759318226336
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.38836981000000004	14.50153029175016
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.612480789953038
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3638483	13.585909636106368
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.349526772757217
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.349526772757217
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.35530065	13.266744752002019
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.3552659	13.265447204755393
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.244350393407366
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.35267945	13.168870483142822
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.35191631999999995	13.140375598817123
MYOCLONIC-ATONIC EPILEPSY	0.3497355	13.05894489417287
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.3497355	13.05894489417287
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.709437941216475
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.3396705	12.683122936265109
OROFACIODIGITAL SYNDROME TYPE 3	0.33798416	12.620155862196736
COG4-CDG	0.3348101	12.501638083387325
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.333874419	12.46670023287594
NEUROMYELITIS OPTICA	0.333333	12.446483924020653
EPIDERMAL NEVUS SYNDROME	0.333333	12.446483924020653
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.446483924020653
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.32145334999999997	12.002903862196614
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30073585999999997	11.229323369922946
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.26693939999999994	9.967380819743974
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25939474	9.685667069823623
HYPEREKPLEXIA 1; HKPX1	0.25465116	9.50854421606385
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.25168634	9.397839351956142
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.334872277887769
PALLISTER-HALL SYNDROME	0.25	9.334872277887769
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.2424996	9.05481117375549
LENNOX-GASTAUT SYNDROME	0.23722246999999996	8.85776583558025
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.237037	8.850840480534732
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.23406925	8.740026211723926
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.436079036406989
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.21946495000000002	8.1947091108921
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21923995000000002	8.186307725842003
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.21840821000000002	8.155250979168361
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.467897822310215
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.467897822310215
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.19404290999999999	7.245463125118684
MYOCLONIC EPILEPSY OF INFANCY	0.19138809999999998	7.146333876030448
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.19138809999999998	7.146333876030448
JUVENILE MYOCLONIC EPILEPSY	0.1829753	6.832204222032791
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.18019682	6.728457198326129
UNILATERAL POLYMICROGYRIA	0.17265286	6.446769586048151
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.16988399999999998	6.343381768226742
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16792089999999998	6.270080617151856
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.955861348380332
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.955861348380332
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15211625999999998	5.679943433959871
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15211625999999998	5.679943433959871
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15081698	5.631428982547016
COMBINED SAPOSIN DEFICIENCY	0.14750815999999997	5.507879334184933
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14520144999999998	5.421747961256427
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.14445954	5.394045420889677
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14285699999999998	5.334207396008852
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.334207396008852
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.14265366000000002	5.326614784292909
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.13416504	5.0096540502308144
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.129196319	4.824124546552979
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.12727819999999998	4.752502963037819
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12468059999999999	4.6555099061216545
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.12180288999999998	4.548057684910453
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.11944024999999998	4.459837914355937
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.11924649999999999	4.452603388340575
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11815324999999999	4.411781991869371
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.11710767999999998	4.372740942239006
DYSTONIA 16; DYT16	0.11644697999999998	4.348070741783005
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11309530000000001	4.2229207229176025
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.11165241899999999	4.169044283528837
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.11165241899999999	4.169044283528837
COMPLEX REGIONAL PAIN SYNDROME	0.11111099999999999	4.148827974673551
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.11052365000000001	4.126896625743883
BILATERAL POLYMICROGYRIA	0.10411521	3.8876087501418537
AICARDI SYNDROME; AIC	0.1036867	3.871608405662663
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.10113961	3.7765013663415217
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09840755	3.6744876417194177
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.663819749680248
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.663819749680248
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.663819749680248
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.663819749680248
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.663819749680248
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.09784830000000001	3.653605532433783
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.09784830000000001	3.653605532433783
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.0978483	3.6536055324337826
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08897250000000001	3.3221876949774782
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.08800626	3.2861087870183328
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08693017	3.2459281361802836
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.0850197	3.1745921624173388
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08123344	3.0332151483738374
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.08102891000000001	3.025578102665852
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.08096026	3.023014746738344
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.0803901	3.001725263626502
TUBEROUS SCLEROSIS COMPLEX	0.07794046	2.910256957519282
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.077916479	2.909361519230898
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8722692548767546
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07607976000000001	2.8407793701294195
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07573894	2.82805332545042
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.07460524999999998	2.785721920039545
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.07413886	2.7683071557128094
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.07300403999999999	2.7259335566792386
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.7218101568966504
SCHINZEL-GIEDION SYNDROME	0.07142860000000001	2.667107431953337
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.6428666356221178
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5095168276083286
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.489300518753042
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.489300518753042
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.489300518753042
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.489300518753042
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.489300518753042
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.489300518753042
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.489300518753042
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.489300518753042
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.489300518753042
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.489300518753042
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0666667	2.489300518753042
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.489300518753042
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.489300518753042
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.489300518753042
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0662919	2.4753056782340326
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06428419	2.400338812549881
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.0636522	2.3767406288262714
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.059865940000000006	2.23536361478277
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05946425	2.220364715401551
PYRIDOXINE-DEPENDENT EPILEPSY	0.05697231	2.1273169489049124
WHITE-SUTTON SYNDROME; WHSUS	0.055555600000000004	2.074417721285687
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.074417721285687
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.074417721285687
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.074417721285687
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.074417721285687
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.074417721285687
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.074417721285687
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.074417721285687
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.074417721285687
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.074417721285687
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.074417721285687
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.074417721285687
GITELMAN SYNDROME	0.055555600000000004	2.074417721285687
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.074417721285687
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.074417721285687
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.074417721285687
MENTAL RETARDATION, X-LINKED 98; MRX98	0.055241379	2.062684869677566
ALG13-CDG	0.053451639999999995	1.9958569297745477
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0533261	1.9911693303114837
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05286995	1.9741369223532497
NEURONAL CEROID LIPOFUSCINOSIS	0.051806869	1.9344420209290527
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9110768356174999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.05073566	1.8944436241373572
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04951706	1.8489417227060212
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04887121	1.8248260136633259
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0485313	1.8121339479194185
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.0473761	1.7689993700977549
SARCOSINEMIA	0.04718771	1.7619649837440299
MERRF	0.0466441	1.7416668640680995
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.04635284	1.730791364469469
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.0453985	1.6951567964307512
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.045321700000000006	1.6922891236669846
ALPERS-HUTTENLOCHER SYNDROME	0.045258650000000004	1.689934868878501
AMISH INFANTILE EPILEPSY SYNDROME	0.04504195	1.6818434015880277
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6774955914758787
DOORS SYNDROME	0.04339331	1.62028402625916
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.0433745	1.619581670468972
FLYNN-AIRD SYNDROME	0.043259859000000005	1.615301034097735
MYOCLONUS AND ATAXIA	0.043165260000000004	1.6117687557672713
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.04305249	1.6075579815801613
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.043033680000000005	1.6068556257899733
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.04292174	1.6026758433788262
ISOLATED CEREBELLAR AGENESIS	0.042823629	1.5990124287626029
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.5965077331724893
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.5965077331724893
SALT-AND-PEPPER SYNDROME	0.04186789	1.563325622778618
ATYPICAL RETT SYNDROME	0.041782759	1.5601468747310627
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.04172856	1.5581231117607055
16P13.11 MICRODELETION SYNDROME	0.0417099	1.5574263568938842
DISTAL MONOSOMY 12Q	0.041666699999999994	1.5558132909642648
COG2-CDG	0.041666699999999994	1.5558132909642648
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0414764	1.5487075861863369
CANAVAN DISEASE	0.04134734	1.5438885517216
CHRISTIANSON SYNDROME	0.04134734	1.5438885517216
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.041346529	1.5438582693959306
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.041346529	1.5438582693959306
HUNTINGTON DISEASE	0.04124134	1.5399305658757756
WEST SYNDROME	0.0412196	1.5391188053824907
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.04080511	1.5236419605406437
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.04073161	1.5208975080909448
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.04068664	1.5192183512655986
JUVENILE ABSENCE EPILEPSY	0.04031741	1.5054314917009404
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.03947121000000001	1.473834816014746
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.4674549909051462
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.03930035	1.4674549909051462
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.03874215	1.4466120880830786
MCLEOD SYNDROME; MCLDS	0.03872334	1.4459097322928902
TRICHOTHIODYSTROPHY	0.03872334	1.4459097322928902
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.03872334	1.4459097322928902
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.038586959	1.4408173354283675
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.438365661912792
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0384081	1.434138831745365
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.03837959	1.4330742829107945
LEIGH SYNDROME	0.037926259	1.4161471349723658
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4145415742800582
MENINGIOMA	0.03780191	1.4115040068408338
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03735259	1.3947266275932315
LISSENCEPHALY 2; LIS2	0.037037	1.382942658224517
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.382942658224517
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.382942658224517
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.382942658224517
AICARDI SYNDROME	0.036931	1.3789846723786925
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03676104	1.3726384528092934
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.036449158999999995	1.3609929756056935
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.035714300000000004	1.3335537159766686
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.03566625	1.3317595535248583
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3317595535248583
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3317595535248583
WOLF-HIRSCHHORN SYNDROME	0.034276619	1.2798714419312847
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.034276619	1.2798714419312847
GRISCELLI SYNDROME TYPE 1	0.034276619	1.2798714419312847
SANDHOFF DISEASE	0.034276618999999994	1.2798714419312844
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.03394444	1.2674680477776987
YOU-HOOVER-FONG SYNDROME; YHFS	0.0337352	1.2596551330759977
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0337352	1.2596551330759977
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0337352	1.2596551330759977
OXOGLUTARIC ACIDURIA	0.0337352	1.2596551330759977
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.033437259999999996	1.248530205690102
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.033437259999999996	1.248530205690102
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.033348539999999996	1.2452174462161252
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.2247172825646124
TUBEROUS SCLEROSIS-1	0.032799519	1.2247172825646124
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.2247172825646124
CHROMOSOME 1P36 DELETION SYNDROME	0.032799519	1.2247172825646124
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2247172825646124
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2247172825646124
3P25.3 MICRODELETION SYNDROME	0.03270400999999999	1.2211510252990572
DIENCEPHALIC SYNDROME	0.0322581	1.2045009737093255
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.2045009737093255
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0322581	1.2045009737093255
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	1.2045009737093255
SLC35A2-CDG	0.0322581	1.2045009737093255
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.2045009737093255
LESCH-NYHAN SYNDROME	0.0322581	1.2045009737093255
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.2045009737093255
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0322581	1.2045009737093255
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0322581	1.2045009737093255
PEHO SYNDROME	0.0322581	1.2045009737093255
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.03142744	1.1734845536839247
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1659968659323852
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.030676639999999998	1.1454500652589719
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02978225	1.1120539995924918
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.029715059999999998	1.1095451593190868
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.029272909999999996	1.0930355042084146
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.029254759	1.0923577551415509
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029165418999999998	1.0890218451843248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0290382	1.0842715527190425
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0688055363290376
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0688055363290376
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.02837791	1.0596166614535762
EPILEPSY, PYRIDOXINE-DEPENDENT	0.027795809999999997	1.0378813448417423
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0372088606428436
GANGLIOCYTOMA	0.027777800000000002	1.0372088606428436
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0372088606428436
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0372088606428436
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0372088606428436
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	1.0372088606428436
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.02749805	1.026763138563887
RETT SYNDROME, CONGENITAL VARIANT	0.027068559000000002	1.010726164045878
CHROMOSOME 17Q12 DELETION SYNDROME	0.027027	1.009174372217891
BENIGN OCCIPITAL EPILEPSY	0.027027	1.009174372217891
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.009174372217891
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.009174372217891
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.009174372217891
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.026288650000000004	0.9816047604323773
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.02600856	0.9711463429271228
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.02562557	0.9568456919922897
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.02543126	0.9495902558630244
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02489579	0.929596079628462
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.02458615	0.9180342802199615
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.0244991	0.9147838776928008
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.024495579000000003	0.9146524053516393
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.0239818	0.8954681599753955
2Q23.1 MICRODUPLICATION SYNDROME	0.023954160000000002	0.8944360964963523
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.023954160000000002	0.8944360964963523
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.023872759	0.8913966247431829
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.02333134	0.8711803158878959
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.022758219000000003	0.8497802705487948
POTOCKI-LUPSKI SYNDROME	0.022758219000000003	0.8497802705487948
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.022736479000000004	0.8489685100555098
ADENYLOSUCCINASE DEFICIENCY	0.022736479000000004	0.8489685100555098
CEREBROTENDINOUS XANTHOMATOSIS	0.022722829	0.8484588260291369
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.02247917	0.8393607234517055
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.022217949999999997	0.829606902105986
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.0222149	0.829493016664196
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0222149	0.829493016664196
GAUCHER DISEASE	0.02208895	0.824790108010596
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.02196765	0.8202608279813648
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.02196765	0.8202608279813648
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.021932899999999998	0.8189632807347383
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.02133566	0.7966626442577557
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02097441	0.7831737538162079
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.774452742739314
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.774452742739314
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.020740849999999998	0.774452742739314
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.020511679999999997	0.7658956520196198
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.0204558	0.7638091213680664
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.020455799999999996	0.7638091213680663
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.02010886	0.7508545590157049
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.02010886	0.7508545590157049
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.02010886	0.7508545590157049
FUMARASE DEFICIENCY; FMRD	0.02004131	0.7483322765262196
BETA-UREIDOPROPIONASE DEFICIENCY	0.02004131	0.7483322765262196
SIALIDOSIS TYPE 1	0.019889589	0.7426670918987259
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.019771659000000004	0.7382636459478009
11Q22.2Q22.3 MICRODELETION SYNDROME	0.019771659000000004	0.7382636459478009
MENTAL RETARDATION, X-LINKED 104; MRX104	0.019562419	0.7304507312460999
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.019562419	0.7304507312460999
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.019235739999999998	0.7182527042826273
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.019230240000000003	0.718047337092514
MELAS	0.01918893	0.7165048427973157
ISOLATED COMPLEX I DEFICIENCY	0.019021	0.710234422390813
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6921453068907221
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.018412489	0.6875129325320539
AYMÉ-GRIPP SYNDROME	0.0183715	0.6859824242128605
CARNOSINASE DEFICIENCY	0.018242500000000002	0.6811656301174706
HYPERPROLINEMIA, TYPE I	0.018185719	0.6790454565862274
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.018085319000000002	0.6752965718794278
FRAGILE X MENTAL RETARDATION SYNDROME	0.018085319000000002	0.6752965718794278
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.018085319000000002	0.6752965718794278
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.018085319000000002	0.6752965718794278
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.018085319000000002	0.6752965718794278
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.018085319000000002	0.6752965718794278
HEART AND BRAIN MALFORMATION SYNDROME	0.018085319000000002	0.6752965718794278
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.018085319000000002	0.6752965718794278
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.018085319000000002	0.6752965718794278
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.018085319000000002	0.6752965718794278
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.018085319000000002	0.6752965718794278
PHELAN-MCDERMID SYNDROME	0.018085319000000002	0.6752965718794278
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.018085319000000002	0.6752965718794278
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.018085319000000002	0.6752965718794278
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.018085319000000002	0.6752965718794278
8Q24.3 MICRODELETION SYNDROME	0.018085319000000002	0.6752965718794278
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.018085319000000002	0.6752965718794278
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.018071669000000002	0.6747868878530551
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.018032399	0.6733205661156445
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.018008939999999998	0.6724446190405765
RING CHROMOSOME 14 SYNDROME	0.01790456	0.6685471231671128
PERMANENT NEONATAL DIABETES MELLITUS	0.017778609999999997	0.6638442145135129
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.017644299999999998	0.6588291477309405
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0175439	0.6550802630241409
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.0175439	0.6550802630241409
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.0175439	0.6550802630241409
MUSCLE-EYE-BRAIN DISEASE	0.017410969000000002	0.6501166873970533
COG8-CDG	0.017390278999999998	0.6493441333673352
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6437850675678967
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6437850675678967
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6437850675678967
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6437850675678967
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6437850675678967
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6437850675678967
MYOPATHY, CONGENITAL	0.0172414	0.6437850675678967
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6437850675678967
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6437850675678967
ERYTHERMALGIA, PRIMARY	0.0172414	0.6437850675678967
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6437850675678967
269800 SENILE PLAQUE FORMATION	0.0172414	0.6437850675678967
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6437850675678967
THUMBS, CONGENITAL CLASPED	0.0172414	0.6437850675678967
MOTION SICKNESS	0.0172414	0.6437850675678967
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6437850675678967
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6437850675678967
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6437850675678967
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6437850675678967
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6437850675678967
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6437850675678967
RHEUMATOID ARTHRITIS	0.0172414	0.6437850675678967
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6437850675678967
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6437850675678967
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6437850675678967
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6437850675678967
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6437850675678967
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6437850675678967
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6437850675678967
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6437850675678967
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6437850675678967
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6437850675678967
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6437850675678967
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6437850675678967
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6437850675678967
CARDIAC ARRHYTHMIA	0.0172414	0.6437850675678967
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6437850675678967
MOSAIC TRISOMY 15	0.0172414	0.6437850675678967
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6437850675678967
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6437850675678967
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6437850675678967
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6437850675678967
CERVICAL RIB	0.0172414	0.6437850675678967
SICKLE CELL ANEMIA	0.0172414	0.6437850675678967
PALMOMENTAL REFLEX	0.0172414	0.6437850675678967
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6437850675678967
TRANSSEXUALITY	0.0172414	0.6437850675678967
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6437850675678967
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6437850675678967
ALCOHOL DEPENDENCE	0.0172414	0.6437850675678967
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6437850675678967
DIASTEMATOMYELIA	0.0172414	0.6437850675678967
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6437850675678967
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6437850675678967
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.017048409	0.6365788822247693
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.016402499999999997	0.6124609701522163
HAREL-YOON SYNDROME; HAYOS	0.016402499999999997	0.6124609701522163
NIEMANN-PICK DISEASE TYPE B	0.016402499999999997	0.6124609701522163
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6086900551468408
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6086900551468408
TRANSIENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6086900551468408
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.01614546	0.6028632278709833
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.01614546	0.6028632278709833
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01614546	0.6028632278709833
PEHO-LIKE SYNDROME; PEHOL	0.01614546	0.6028632278709833
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.01614546	0.6028632278709833
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.01614546	0.6028632278709833
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.015928939	0.5947784443490612
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.015928939	0.5947784443490612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.01580464	0.5901371831919845
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01580464	0.5901371831919845
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.015717118999999998	0.5868691937654524
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.015652919	0.584471998564491
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.015652919	0.584471998564491
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.015618499999999999	0.5831868106887604
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.01559676	0.5823750501954753
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.015588119	0.5820523996700624
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01538752	0.5745621354937743
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.015384939999999998	0.5744657996118665
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.015384939999999998	0.5744657996118665
CENTRAL BILATERAL MACROGYRIA	0.015238429000000001	0.5689951537226442
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.015238429000000001	0.5689951537226442
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.015238429	0.5689951537226441
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.015175699999999999	0.5666528849101656
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.015175699999999999	0.5666528849101656
MENTAL RETARDATION, X-LINKED 41	0.014925399999999998	0.5573068107855443
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.014925399999999998	0.5573068107855443
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5573068107855443
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.014925399999999998	0.5573068107855443
METACHROMATIC LEUKODYSTROPHY	0.014875869000000002	0.5554573485503602
PELIZAEUS-MERZBACHER DISEASE	0.014875869000000002	0.5554573485503602
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.014788019	0.5521770744319103
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.014657739999999999	0.5473125231299466
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.014657739999999999	0.5473125231299466
XERODERMA PIGMENTOSUM	0.014651399	0.5470757534294903
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.013932159999999999	0.5202197366203873
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.01391042	0.5194079761271022
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.01391042	0.5194079761271022
ISOLATED GLYCEROL KINASE DEFICIENCY	0.013761329000000001	0.5138409943559721
ARGININEMIA	0.013761329000000001	0.5138409943559721
FOUNTAIN SYNDROME	0.013761329	0.513840994355972
ZLOTOGORA-OGUR SYNDROME	0.013761329	0.513840994355972
SMITH-MAGENIS SYNDROME	0.013761329	0.513840994355972
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5114987255434935
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.013698599999999998	0.5114987255434935
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.013698599999999998	0.5114987255434935
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.013698599999999998	0.5114987255434935
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5114987255434935
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5114987255434935
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5114987255434935
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5114987255434935
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.013698599999999998	0.5114987255434935
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.013698599999999998	0.5114987255434935
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5114987255434935
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5114987255434935
19P13.3 MICRODUPLICATION SYNDROME	0.013698599999999998	0.5114987255434935
OLIVER SYNDROME	0.01345251	0.5023098506680319
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.01345251	0.5023098506680319
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.01345251	0.5023098506680319
ADNP SYNDROME	0.013398769000000001	0.5003031891836881
NASU-HAKOLA DISEASE	0.013398769000000001	0.5003031891836881
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.013310919	0.49702291506523827
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.013310919	0.49702291506523827
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.013219910000000001	0.49362468550068517
CANAVAN DISEASE	0.013174299	0.4919215940628182
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.01317051	0.4917801147385745
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.0129714	0.4843454490615735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.0129714	0.4843454490615735
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.012948359000000001	0.48348510989295435
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.012908900000000001	0.48201173099210165
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.012739119000000002	0.4756721951912534
TRISOMY 13	0.012738069000000001	0.47563298872768633
WORSTER-DROUGHT SYNDROME	0.012738069000000001	0.47563298872768633
ALEXANDER DISEASE	0.012688099000000001	0.4737671344567821
HSD10 DISEASE	0.012666358999999999	0.47295537396349685
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.012234829	0.45684226422718927
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01219665	0.4554166798723994
TRISOMY 20P	0.01219665	0.4554166798723994
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.01219665	0.4554166798723994
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.01219665	0.4554166798723994
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.012078419000000002	0.45100199473525165
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.01174624	0.43859860058166567
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01171515	0.4374377158651876
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.01171515	0.4374377158651876
ATAXIA-PANCYTOPENIA SYNDROME	0.01171045	0.4372622202663633
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.01169341	0.43662595537190246
MYOCLONIC EPILEPSY, JUVENILE, 2	0.01169341	0.43662595537190246
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.01169341	0.43662595537190246
NIEMANN-PICK DISEASE TYPE C	0.011664839	0.43555912882849623
1P36 DELETION SYNDROME	0.011624579	0.4340558409968652
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.011602839	0.4332440805035802
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.011602839	0.4332440805035802
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.42919128969490145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.011494299999999999	0.42919128969490145
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.011494299999999999	0.42919128969490145
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.42919128969490145
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.011494299999999999	0.42919128969490145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.011494299999999999	0.42919128969490145
WRINKLY SKIN SYNDROME	0.011494299999999999	0.42919128969490145
DESMOSTEROLOSIS	0.011494299999999999	0.42919128969490145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.42919128969490145
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.011494299999999999	0.42919128969490145
PERLMAN SYNDROME	0.011494299999999999	0.42919128969490145
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.011494299999999999	0.42919128969490145
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.011494299999999999	0.42919128969490145
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.011494299999999999	0.42919128969490145
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.42919128969490145
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.011342579	0.42352610506740784
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.011342579	0.42352610506740784
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.011342579	0.42352610506740784
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.011262019000000002	0.42051803582458136
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.011262019000000002	0.42051803582458136
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.011262019000000002	0.42051803582458136
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.011210999000000001	0.41861297509011003
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.011189258999999998	0.4178012145968248
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.01112342	0.41534281997320943
RETT SYNDROME	0.011001759000000002	0.4108000603884091
TAY-SACHS DISEASE	0.011001759000000002	0.4108000603884091
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.011001759000000002	0.4108000603884091
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.010980019	0.4099882998951239
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.010980019	0.4099882998951239
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.010980019	0.4099882998951239
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.010980018999999999	0.40998829989512386
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.010980018999999999	0.40998829989512386
WHIPPLE DISEASE	0.010980018999999999	0.40998829989512386
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.0109456	0.4087031120193934
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.01073636	0.4008901973176925
GAUCHER DISEASE TYPE 3	0.01073636	0.4008901973176925
BIOTINIDASE DEFICIENCY	0.01073636	0.4008901973176925
KRABBE DISEASE	0.01073636	0.4008901973176925
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.0107206	0.40030172696929445
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.01064784	0.397584905741538
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.010601319000000001	0.39584783536857954
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.010601319000000001	0.39584783536857954
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.010601319000000001	0.39584783536857954
CORNELIA DE LANGE SYNDROME 3	0.010601319000000001	0.39584783536857954
NEUROFIBROMATOSIS TYPE 1	0.010565529	0.39451145505327706
TYROSINEMIA TYPE 2	0.010565529	0.39451145505327706
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.010565529	0.39451145505327706
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.010565529	0.39451145505327706
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.010528559	0.393131014140823
DYSTONIA-APHONIA SYNDROME	0.010528559	0.393131014140823
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.010438600000000001	0.38977199103983706
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.010438600000000001	0.38977199103983706
SYMMETRICAL THALAMIC CALCIFICATIONS	0.010341059000000001	0.3861298599324073
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.010341059000000001	0.3861298599324073
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.010115119	0.37769337576254336
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.010115119	0.37769337576254336
BARDET-BIEDL SYNDROME 1; BBS1	0.010024110000000001	0.37429514619799026
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.010024110000000001	0.37429514619799026
CAMURATI-ENGELMANN DISEASE	0.010024110000000001	0.37429514619799026
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.010024110000000001	0.37429514619799026
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.010024110000000001	0.37429514619799026
PENDRED SYNDROME	0.010024110000000001	0.37429514619799026
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.010024110000000001	0.37429514619799026
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.010024110000000001	0.37429514619799026
VON HIPPEL-LINDAU DISEASE	0.010024110000000001	0.37429514619799026
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.010024110000000001	0.37429514619799026
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00998714	0.3729147052855362
DYSTONIA 28, CHILDHOOD-ONSET	0.00998714	0.3729147052855362
SPINOCEREBELLAR ATAXIA TYPE 14	0.00998714	0.3729147052855362
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.009978499	0.3725920547601233
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.009865479	0.3683719457007357
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.009865479	0.3683719457007357
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.009865479	0.3683719457007357
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.009865479	0.3683719457007357
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.009865479	0.3683719457007357
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00979964	0.36591355107712037
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.009777899999999999	0.36510179058383524
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0095737	0.3574770669072565
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0095737	0.3574770669072565
NORRIE DISEASE	0.009524659000000001	0.35564590102173693
RETT SYNDROME; RTT	0.009524659000000001	0.35564590102173693
NEONATAL ADRENOLEUKODYSTROPHY	0.009524659000000001	0.35564590102173693
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.009524659000000001	0.35564590102173693
CADASIL	0.009524659000000001	0.35564590102173693
KRABBE DISEASE	0.009524659000000001	0.35564590102173693
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.009524659	0.35564590102173693
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.009524659	0.35564590102173693
SCHINDLER DISEASE, TYPE I	0.009502919	0.3548341405284518
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.009502919	0.3548341405284518
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.009502919	0.3548341405284518
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.009502919	0.3548341405284518
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.009502918999999999	0.35483414052845175
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.009502918999999999	0.35483414052845175
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.009502918999999999	0.35483414052845175
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.009502918999999999	0.35483414052845175
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00943708	0.35237574590483645
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.00925926	0.3457360379510204
XQ12-Q13.3 DUPLICATION SYNDROME	0.00925926	0.3457360379510204
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.00925926	0.3457360379510204
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00925926	0.3457360379510204
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00925926	0.3457360379510204
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.3457360379510204
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3457360379510204
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00925926	0.3457360379510204
GLYCINE ENCEPHALOPATHY	0.00925926	0.3457360379510204
GAUCHER DISEASE TYPE 2	0.00925926	0.3457360379510204
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.3457360379510204
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00925926	0.3457360379510204
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00925926	0.3457360379510204
CARNOSINEMIA	0.00925926	0.3457360379510204
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3457360379510204
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3457360379510204
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.3457360379510204
HYDROXYLYSINURIA	0.00925926	0.3457360379510204
PAINE SYNDROME	0.00925926	0.3457360379510204
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3457360379510204
ROIFMAN-CHITAYAT SYNDROME	0.00925926	0.3457360379510204
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00925926	0.3457360379510204
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3457360379510204
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.009088429	0.339357295686605
MICROPHTHALMIA, LENZ TYPE	0.009088429	0.339357295686605
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.009088429	0.339357295686605
DDOST-CDG	0.009088429	0.339357295686605
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.009088429	0.339357295686605
CORNELIA DE LANGE SYNDROME	0.009088429	0.339357295686605
COFFIN-LOWRY SYNDROME	0.009088429	0.339357295686605
STURGE-WEBER SYNDROME	0.009088429	0.339357295686605
TAKAYASU ARTERITIS	0.009088429	0.339357295686605
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.009088429	0.339357295686605
WHIM SYNDROME	0.009088429	0.339357295686605
22Q11.2 MICRODUPLICATION SYNDROME	0.009088429	0.339357295686605
COHEN SYNDROME	0.009088429	0.339357295686605
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.009088429	0.339357295686605
ASPARTYLGLUCOSAMINURIA	0.009088429	0.339357295686605
CONGENITAL RUBELLA SYNDROME	0.009088429	0.339357295686605
FRAGILE X SYNDROME	0.009088429	0.339357295686605
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.009088429	0.339357295686605
SIMPSON-GOLABI-BEHMEL SYNDROME	0.009088429	0.339357295686605
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.008863959000000001	0.33097570056573516
GALLOWAY-MOWAT SYNDROME	0.008863959000000001	0.33097570056573516
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.008863959000000001	0.33097570056573516
PHAKOMATOSIS PIGMENTOVASCULARIS	0.008863959000000001	0.33097570056573516
ZELLWEGER SYNDROME	0.008863959000000001	0.33097570056573516
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00872859	0.32592109126419355
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.00872859	0.32592109126419355
WAISMAN SYNDROME; WSMN	0.008638019	0.3225392163958713
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.008638019	0.3225392163958713
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.008638019	0.3225392163958713
POSTENCEPHALITIC PARKINSONISM	0.008638019	0.3225392163958713
TOLUENE EMBRYOPATHY	0.00854701	0.31914098683131814
PSYCHOGENIC MOVEMENT DISORDERS	0.00854701	0.31914098683131814
PRIMARY PROGRESSIVE FREEZING GAIT	0.00854701	0.31914098683131814
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.00854701	0.31914098683131814
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00854701	0.31914098683131814
ALZHEIMER DISEASE 10	0.00854701	0.31914098683131814
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.00854701	0.31914098683131814
GOLDENHAR SYNDROME	0.00854701	0.31914098683131814
TRISOMY XQ28	0.00854701	0.31914098683131814
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00854701	0.31914098683131814
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00854701	0.31914098683131814
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00854701	0.31914098683131814
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00854701	0.31914098683131814
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00854701	0.31914098683131814
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00854701	0.31914098683131814
HISTIDINEMIA	0.00854701	0.31914098683131814
BARDET-BIEDL SYNDROME	0.00854701	0.31914098683131814
HISTIDINEMIA	0.00854701	0.31914098683131814
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.00854701	0.31914098683131814
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.00854701	0.31914098683131814
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00854701	0.31914098683131814
ALOPECIA ANTIBODY DEFICIENCY	0.00854701	0.31914098683131814
3C SYNDROME	0.00854701	0.31914098683131814
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00854701	0.31914098683131814
15Q26 OVERGROWTH SYNDROME	0.00854701	0.31914098683131814
RECESSIVE X-LINKED ICHTHYOSIS	0.00854701	0.31914098683131814
OTOFACIOCERVICAL SYNDROME	0.00854701	0.31914098683131814
BRANCHIO-OCULO-FACIAL SYNDROME	0.00854701	0.31914098683131814
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00854701	0.31914098683131814
FLOATING-HARBOR SYNDROME	0.00854701	0.31914098683131814
FREEMAN-SHELDON SYNDROME	0.00854701	0.31914098683131814
DYSLEXIA, SUSCEPTIBILITY TO, 1	0.00854701	0.31914098683131814
ALBINISM-DEAFNESS SYNDROME	0.00854701	0.31914098683131814
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.00854701	0.31914098683131814
BECKWITH-WIEDEMANN SYNDROME	0.00854701	0.31914098683131814
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00854701	0.31914098683131814
GERMAN SYNDROME	0.00854701	0.31914098683131814
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00854701	0.31914098683131814
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.00854701	0.31914098683131814
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00854701	0.31914098683131814
NEURALGIC AMYOTROPHY	0.00854701	0.31914098683131814
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.00854701	0.31914098683131814
SHORT SYNDROME	0.00854701	0.31914098683131814
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.00854701	0.31914098683131814
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00851935	0.31810817656249263
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.008501399	0.31743789539345113
GM2 GANGLIOSIDOSIS, AB VARIANT	0.008501399	0.31743789539345113
FABRY DISEASE	0.008501399	0.31743789539345113
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.008428779	0.3147263016941704
DISTAL MONOSOMY 10Q	0.008428779	0.3147263016941704
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.008428779	0.3147263016941704
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.008428779	0.3147263016941704
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.008428779	0.3147263016941704
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.008428779	0.3147263016941704
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.008377759	0.312821240959699
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.008356019	0.31200948046641386
EARLY-ONSET LAFORA BODY DISEASE	0.008356019	0.31200948046641386
KUFOR-RAKEB SYNDROME	0.008356019	0.31200948046641386
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.008356019	0.31200948046641386
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.008356019	0.31200948046641386
CARTILAGE-HAIR HYPOPLASIA	0.00832254	0.31075939171044825
CHILDHOOD APRAXIA OF SPEECH	0.0080966	0.30232290754058444
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.0080966	0.30232290754058444
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0080966	0.30232290754058444
CHOREOACANTHOCYTOSIS	0.008015199	0.29928343578741506
WOLFRAM SYNDROME	0.008015199	0.29928343578741506
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.008015199	0.29928343578741506
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.008015199	0.29928343578741506
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00788736	0.29450999283888346
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.00788736	0.29450999283888346
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0078146	0.291793171611127
BRAIN-LUNG-THYROID SYNDROME	0.0078146	0.291793171611127
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0078146	0.291793171611127
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28317032605110737
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.007473779999999999	0.27906712693212815
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.007473779999999999	0.27906712693212815
ATAXIA-TELANGIECTASIA	0.0073544990000000005	0.2746132353314133
GALACTOSEMIA	0.0073544990000000005	0.2746132353314133
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0073544990000000005	0.2746132353314133
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26295401719582057
1Q44 MICRODELETION SYNDROME	0.00704225	0.26295401719582057
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26295401719582057
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26295401719582057
W SYNDROME	0.00704225	0.26295401719582057
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.00704225	0.26295401719582057
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26295401719582057
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26295401719582057
OROFACIODIGITAL SYNDROME TYPE 2	0.00704225	0.26295401719582057
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.26295401719582057
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26295401719582057
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00704225	0.26295401719582057
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.26295401719582057
PELGER-HUET ANOMALY; PHA	0.00704225	0.26295401719582057
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.26295401719582057
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26295401719582057
X SMALL RINGS	0.00704225	0.26295401719582057
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26295401719582057
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26295401719582057
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00704225	0.26295401719582057
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26295401719582057
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.00704225	0.26295401719582057
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00704225	0.26295401719582057
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26295401719582057
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.26295401719582057
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00704225	0.26295401719582057
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26295401719582057
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.26295401719582057
AMISH LETHAL MICROCEPHALY	0.00704225	0.26295401719582057
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26295401719582057
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26295401719582057
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.0069516790000000005	0.25957214232749826
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.0069516790000000005	0.25957214232749826
MENTAL RETARDATION, X-LINKED 101; MRX101	0.0069516790000000005	0.25957214232749826
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.0069516790000000005	0.25957214232749826
21Q22.11Q22.12 MICRODELETION SYNDROME	0.0069516790000000005	0.25957214232749826
MENTAL RETARDATION, X-LINKED 100	0.0069516790000000005	0.25957214232749826
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.0069516790000000005	0.25957214232749826
KOOLEN-DE VRIES SYNDROME; KDVS	0.0069516790000000005	0.25957214232749826
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.0069516790000000005	0.25957214232749826
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.0069516790000000005	0.25957214232749826
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.0069516790000000005	0.25957214232749826
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.0069516790000000005	0.25957214232749826
MAN1B1-CDG	0.0069516790000000005	0.25957214232749826
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.0069516790000000005	0.25957214232749826
WILSON-TURNER SYNDROME	0.0069516790000000005	0.25957214232749826
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0069516790000000005	0.25957214232749826
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.0069516790000000005	0.25957214232749826
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.0069516790000000005	0.25957214232749826
MENTAL RETARDATION, X-LINKED 1	0.0069516790000000005	0.25957214232749826
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.0069516790000000005	0.25957214232749826
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0069516790000000005	0.25957214232749826
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0069516790000000005	0.25957214232749826
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.0069516790000000005	0.25957214232749826
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.0069516790000000005	0.25957214232749826
KOOLEN-DE VRIES SYNDROME	0.0069516790000000005	0.25957214232749826
SLC39A8-CDG	0.0069516790000000005	0.25957214232749826
8P23.1 MICRODELETION SYNDROME	0.0069516790000000005	0.25957214232749826
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.0069516790000000005	0.25957214232749826
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.0069516790000000005	0.25957214232749826
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.0069516790000000005	0.25957214232749826
MENTAL RETARDATION, X-LINKED 14	0.0069516790000000005	0.25957214232749826
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0069516790000000005	0.25957214232749826
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0069516790000000005	0.25957214232749826
MEHMO SYNDROME; MEHMO	0.0069516790000000005	0.25957214232749826
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.0069516790000000005	0.25957214232749826
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.0069516790000000005	0.25957214232749826
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.0069516790000000005	0.25957214232749826
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0069516790000000005	0.25957214232749826
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0069516790000000005	0.25957214232749826
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.0069516790000000005	0.25957214232749826
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.0069516790000000005	0.25957214232749826
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0069516790000000005	0.25957214232749826
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.0069516790000000005	0.25957214232749826
PITT-HOPKINS-LIKE SYNDROME	0.0069516790000000005	0.25957214232749826
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.0069516790000000005	0.25957214232749826
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0069516790000000005	0.25957214232749826
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.0069516790000000005	0.25957214232749826
PARTINGTON SYNDROME	0.006900659	0.2576670815930269
HUNTINGTON DISEASE-LIKE 1	0.006900659	0.2576670815930269
SUPRABULBAR PARESIS, CONGENITAL	0.006900659	0.2576670815930269
SPINOCEREBELLAR ATAXIA TYPE 13	0.006878918999999999	0.25685532109974174
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.006878918999999999	0.25685532109974174
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.006878918999999999	0.25685532109974174
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.006878918999999999	0.25685532109974174
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.006878918999999999	0.25685532109974174
ADULT-ONSET DYSTONIA-PARKINSONISM	0.006878918999999999	0.25685532109974174
ALZHEIMER DISEASE 3; AD	0.006878918999999999	0.25685532109974174
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.006878918999999999	0.25685532109974174
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.006813079999999999	0.25439692647612633
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.006813079999999999	0.25439692647612633
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.006813079999999999	0.25439692647612633
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.006813079999999999	0.25439692647612633
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.006813079999999999	0.25439692647612633
IMMUNODEFICIENCY 23; IMD23	0.006813079999999999	0.25439692647612633
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0066914190000000005	0.24985416689132597
BANGSTAD SYNDROME	0.0066914190000000005	0.24985416689132597
HARTNUP DISEASE	0.0066914190000000005	0.24985416689132597
ANGELMAN SYNDROME	0.0066914190000000005	0.24985416689132597
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0066914190000000005	0.24985416689132597
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0066914190000000005	0.24985416689132597
MILLER-DIEKER SYNDROME	0.0066914190000000005	0.24985416689132597
COCKAYNE SYNDROME	0.0066914190000000005	0.24985416689132597
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0066914190000000005	0.24985416689132597
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0066914190000000005	0.24985416689132597
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0066914190000000005	0.24985416689132597
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0066696789999999995	0.24904240639804084
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.0066696789999999995	0.24904240639804084
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.0066696789999999995	0.24904240639804084
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.0066696789999999995	0.24904240639804084
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.0066696789999999995	0.24904240639804084
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.0066696789999999995	0.24904240639804084
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.0066696789999999995	0.24904240639804084
THYROCEREBRORETINAL SYNDROME	0.0066696789999999995	0.24904240639804084
HEREDITARY HYPEREKPLEXIA	0.0066696789999999995	0.24904240639804084
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0066696789999999995	0.24904240639804084
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.0066696789999999995	0.24904240639804084
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0066696789999999995	0.24904240639804084
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.006538099	0.24412927642074297
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.006538099	0.24412927642074297
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.006538099	0.24412927642074297
LYNCH SYNDROME	0.006538099	0.24412927642074297
FAMILIAL COLORECTAL CANCER TYPE X	0.006538099	0.24412927642074297
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006538099	0.24412927642074297
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.006538099	0.24412927642074297
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.006538099	0.24412927642074297
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.006538099	0.24412927642074297
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.006538099	0.24412927642074297
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.006538099	0.24412927642074297
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.006538099	0.24412927642074297
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00641026	0.23935583347221137
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.00641026	0.23935583347221137
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.00641026	0.23935583347221137
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00641026	0.23935583347221137
AU-KLINE SYNDROME; AUKS	0.00641026	0.23935583347221137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00641026	0.23935583347221137
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00641026	0.23935583347221137
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00641026	0.23935583347221137
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00641026	0.23935583347221137
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.00641026	0.23935583347221137
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.00641026	0.23935583347221137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.00641026	0.23935583347221137
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.00641026	0.23935583347221137
TRIGEMINAL NEURALGIA	0.00641026	0.23935583347221137
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00641026	0.23935583347221137
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.00641026	0.23935583347221137
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.00641026	0.23935583347221137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00641026	0.23935583347221137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.00641026	0.23935583347221137
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00641026	0.23935583347221137
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.00641026	0.23935583347221137
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.00641026	0.23935583347221137
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.00641026	0.23935583347221137
ALAZAMI-YUAN SYNDROME	0.00641026	0.23935583347221137
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.00641026	0.23935583347221137
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.00641026	0.23935583347221137
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00641026	0.23935583347221137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.00641026	0.23935583347221137
SOTOS SYNDROME 3	0.00641026	0.23935583347221137
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.00641026	0.23935583347221137
FRIED SYNDROME	0.00641026	0.23935583347221137
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00641026	0.23935583347221137
17P11.2 MICRODUPLICATION SYNDROME	0.0063592399999999995	0.23745077273774
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0063592399999999995	0.23745077273774
CARDIOFACIOCUTANEOUS SYNDROME	0.0063592399999999995	0.23745077273774
2P15P16.1 MICRODELETION SYNDROME	0.0063592399999999995	0.23745077273774
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.006337499999999999	0.2366390122444549
DYSTONIA 6, TORSION	0.006337499999999999	0.2366390122444549
DYSTONIA 26, MYOCLONIC; DYT26	0.006337499999999999	0.2366390122444549
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.006337499999999999	0.2366390122444549
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.006337499999999999	0.2366390122444549
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.006337499999999999	0.2366390122444549
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.006337499999999999	0.2366390122444549
SPINOCEREBELLAR ATAXIA 2; SCA2	0.006337499999999999	0.2366390122444549
KUFOR-RAKEB SYNDROME	0.006337499999999999	0.2366390122444549
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.006337499999999999	0.2366390122444549
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.006328859000000001	0.23631636171904205
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.006328859000000001	0.23631636171904205
MUCOPOLYSACCHARIDOSIS TYPE 3	0.006328859000000001	0.23631636171904205
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.006328859000000001	0.23631636171904205
ETHYLMALONIC ENCEPHALOPATHY	0.006328859000000001	0.23631636171904205
ALEXANDER DISEASE	0.006328859000000001	0.23631636171904205
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.006328859000000001	0.23631636171904205
BEHÇET DISEASE	0.006328859000000001	0.23631636171904205
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.006328859000000001	0.23631636171904205
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.006328859000000001	0.23631636171904205
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006328859000000001	0.23631636171904205
DILATED CARDIOMYOPATHY WITH ATAXIA	0.006328859000000001	0.23631636171904205
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.006328859000000001	0.23631636171904205
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.006328859000000001	0.23631636171904205
TRIPLE A SYNDROME	0.006328859000000001	0.23631636171904205
CHÉDIAK-HIGASHI SYNDROME	0.006328859000000001	0.23631636171904205
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.006328859000000001	0.23631636171904205
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.006328859000000001	0.23631636171904205
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.006328859000000001	0.23631636171904205
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.006149999999999999	0.2296378580360391
MUCOLIPIDOSIS TYPE IV	0.006149999999999999	0.2296378580360391
ARGININOSUCCINIC ACIDURIA	0.006149999999999999	0.2296378580360391
BAKER-GORDON SYNDROME; BAGOS	0.006149999999999999	0.2296378580360391
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.00612826	0.228826097542754
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.00612826	0.228826097542754
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.00612826	0.228826097542754
POLYMYOCLONUS, INFANTILE	0.00612826	0.228826097542754
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.00612826	0.228826097542754
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00612826	0.228826097542754
CEREBELLOPARENCHYMAL DISORDER V	0.00612826	0.228826097542754
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00612826	0.228826097542754
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.00599668	0.2239129675654561
ATAXIA WITH VITAMIN E DEFICIENCY	0.00599668	0.2239129675654561
WILLIAMS SYNDROME	0.00599668	0.2239129675654561
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.005877399	0.21945907596474115
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.005877399	0.21945907596474115
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.005877399	0.21945907596474115
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.005877399	0.21945907596474115
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.005877399	0.21945907596474115
REFSUM DISEASE	0.00578744	0.21610005286375514
NEUROFERRITINOPATHY	0.00578744	0.21610005286375514
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.005668159000000001	0.21164616126304026
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.005668159000000001	0.21164616126304026
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.005668159000000001	0.21164616126304026
CYCLIC VOMITING SYNDROME	0.005668159000000001	0.21164616126304026
COWDEN SYNDROME	0.005668159000000001	0.21164616126304026
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.005668159000000001	0.21164616126304026
SPINOCEREBELLAR ATAXIA 1	0.00533598	0.1992427671094543
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00533598	0.1992427671094543
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00533598	0.1992427671094543
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.00533598	0.1992427671094543
SUSAC SYNDROME	0.00533598	0.1992427671094543
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00533598	0.1992427671094543
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00533598	0.1992427671094543
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00533598	0.1992427671094543
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00533598	0.1992427671094543
SPINOCEREBELLAR ATAXIA 42	0.00533598	0.1992427671094543
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.00533598	0.1992427671094543
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00533598	0.1992427671094543
SPINOCEREBELLAR ATAXIA TYPE 29	0.00533598	0.1992427671094543
SPINOCEREBELLAR ATAXIA 5; SCA5	0.00533598	0.1992427671094543
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.00533598	0.1992427671094543
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.00533598	0.1992427671094543
SPINOCEREBELLAR ATAXIA TYPE 21	0.00533598	0.1992427671094543
EPISODIC ATAXIA TYPE 7	0.00533598	0.1992427671094543
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00533598	0.1992427671094543
DERMOTRICHIC SYNDROME	0.005214319	0.19470000752465388
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.005214319	0.19470000752465388
KBG SYNDROME	0.005214319	0.19470000752465388
KABUKI SYNDROME	0.005214319	0.19470000752465388
ANGELMAN SYNDROME	0.005214319	0.19470000752465388
ANGELMAN SYNDROME (TYPE 2)	0.005214319	0.19470000752465388
ANGELMAN SYNDROME (TYPE 1)	0.005214319	0.19470000752465388
SOTOS SYNDROME	0.005214319	0.19470000752465388
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.005214319	0.19470000752465388
AUTISM	0.005214319	0.19470000752465388
ADAMS-OLIVER SYNDROME	0.005214319	0.19470000752465388
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.005214319	0.19470000752465388
VICI SYNDROME	0.005214319	0.19470000752465388
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.005214319	0.19470000752465388
SCHIZENCEPHALY	0.005214319	0.19470000752465388
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.005214319	0.19470000752465388
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.005214319	0.19470000752465388
MEHMO SYNDROME	0.005214319	0.19470000752465388
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.005214319	0.19470000752465388
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.005214319	0.19470000752465388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.005214319	0.19470000752465388
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.005214319	0.19470000752465388
SMITH-MAGENIS SYNDROME; SMS	0.005214319	0.19470000752465388
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.005214319	0.19470000752465388
GAPO SYNDROME; GAPOS	0.005214319	0.19470000752465388
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.005214319	0.19470000752465388
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.005214319	0.19470000752465388
PRIMARY CUTIS VERTICIS GYRATA	0.005214319	0.19470000752465388
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.005214319	0.19470000752465388
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.005214319	0.19470000752465388
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.005214319	0.19470000752465388
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.005214319	0.19470000752465388
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.005214319	0.19470000752465388
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.005214319	0.19470000752465388
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.005214319	0.19470000752465388
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.005214319	0.19470000752465388
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.005214319	0.19470000752465388
NODULAR NEURONAL HETEROTOPIA	0.005214319	0.19470000752465388
EPILEPSY, READING	0.005214319	0.19470000752465388
EPILEPSY, BENIGN OCCIPITAL	0.005214319	0.19470000752465388
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.005214319	0.19470000752465388
OCULOCEREBRORENAL SYNDROME OF LOWE	0.005214319	0.19470000752465388
SEVERE CANAVAN DISEASE	0.005214319	0.19470000752465388
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.005214319	0.19470000752465388
20P13 MICRODELETION SYNDROME	0.005214319	0.19470000752465388
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.005214319	0.19470000752465388
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.005214319	0.19470000752465388
MENTAL RETARDATION, X-LINKED 82	0.005214319	0.19470000752465388
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.005214319	0.19470000752465388
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.005214319	0.19470000752465388
TEMPLE-BARAITSER SYNDROME	0.005214319	0.19470000752465388
NEUROCUTANEOUS MELANOCYTOSIS	0.005214319	0.19470000752465388
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.005214319	0.19470000752465388
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.005214319	0.19470000752465388
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.005214319	0.19470000752465388
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.005214319	0.19470000752465388
LINEAR NEVUS SEBACEUS SYNDROME	0.005214319	0.19470000752465388
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.005214319	0.19470000752465388
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.005214319	0.19470000752465388
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.005214319	0.19470000752465388
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.005214319	0.19470000752465388
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.005214319	0.19470000752465388
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.005214319	0.19470000752465388
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.005214319	0.19470000752465388
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.005214319	0.19470000752465388
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.005214319	0.19470000752465388
QAZI-MARKOUIZOS SYNDROME	0.005214319	0.19470000752465388
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.005192578999999999	0.19388824703136873
THYROCEREBRORENAL SYNDROME	0.005192578999999999	0.19388824703136873
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.005192578999999999	0.19388824703136873
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.005192578999999999	0.19388824703136873
PEHO SYNDROME; PEHO	0.005192578999999999	0.19388824703136873
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.005192578999999999	0.19388824703136873
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.005192578999999999	0.19388824703136873
INHERITED CREUTZFELDT-JAKOB DISEASE	0.005192578999999999	0.19388824703136873
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.005192578999999999	0.19388824703136873
GLYCINE ENCEPHALOPATHY; GCE	0.005192578999999999	0.19388824703136873
LATHOSTEROLOSIS	0.005192578999999999	0.19388824703136873
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.005192578999999999	0.19388824703136873
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.005192578999999999	0.19388824703136873
BENIGN FAMILIAL INFANTILE EPILEPSY	0.005192578999999999	0.19388824703136873
HYPEREKPLEXIA 4; HKPX4	0.005192578999999999	0.19388824703136873
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.005192578999999999	0.19388824703136873
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.005192578999999999	0.19388824703136873
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.005192578999999999	0.19388824703136873
NIPAH VIRUS DISEASE	0.005192578999999999	0.19388824703136873
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.005192578999999999	0.19388824703136873
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.005192578999999999	0.19388824703136873
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.005192578999999999	0.19388824703136873
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.005192578999999999	0.19388824703136873
ATYPICAL JUVENILE PARKINSONISM	0.005192578999999999	0.19388824703136873
NEURAMINIDASE DEFICIENCY	0.005192578999999999	0.19388824703136873
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.005192578999999999	0.19388824703136873
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.005192578999999999	0.19388824703136873
JUVENILE HUNTINGTON DISEASE	0.005192578999999999	0.19388824703136873
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.005192578999999999	0.19388824703136873
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.005126739999999999	0.19142985240775334
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.005126739999999999	0.19142985240775334
NON-DISTAL MONOSOMY 10Q	0.005126739999999999	0.19142985240775334
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.005126739999999999	0.19142985240775334
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.005126739999999999	0.19142985240775334
JOUBERT SYNDROME 4	0.005126739999999999	0.19142985240775334
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.005126739999999999	0.19142985240775334
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.005126739999999999	0.19142985240775334
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.005126739999999999	0.19142985240775334
USHER SYNDROME	0.005126739999999999	0.19142985240775334
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.005126739999999999	0.19142985240775334
SPINOCEREBELLAR ATAXIA 32; SCA32	0.005126739999999999	0.19142985240775334
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.005126739999999999	0.19142985240775334
SNEDDON SYNDROME	0.004851759000000001	0.18116220235236993
14Q12 MICRODELETION SYNDROME	0.004851759000000001	0.18116220235236993
MENKES DISEASE	0.004851759000000001	0.18116220235236993
MULTIPLE SULFATASE DEFICIENCY	0.004851759000000001	0.18116220235236993
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.004851759000000001	0.18116220235236993
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.004851759000000001	0.18116220235236993
OPTIC PATHWAY GLIOMA	0.004851759000000001	0.18116220235236993
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.004851759000000001	0.18116220235236993
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004851759000000001	0.18116220235236993
ASPARTYLGLUCOSAMINURIA; AGU	0.004851759000000001	0.18116220235236993
MUCOPOLYSACCHARIDOSIS TYPE 2	0.004851759000000001	0.18116220235236993
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.004851759000000001	0.18116220235236993
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.004851759000000001	0.18116220235236993
ADIPOSIS DOLOROSA	0.004851759000000001	0.18116220235236993
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.004851759000000001	0.18116220235236993
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.004851759000000001	0.18116220235236993
DYSOSTEOSCLEROSIS	0.004851759000000001	0.18116220235236993
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004851759000000001	0.18116220235236993
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.004851759000000001	0.18116220235236993
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.004851759000000001	0.18116220235236993
CHILDHOOD DISINTEGRATIVE DISORDER	0.004851759000000001	0.18116220235236993
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.004851759000000001	0.18116220235236993
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.004851759000000001	0.18116220235236993
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.004851759000000001	0.18116220235236993
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004851759000000001	0.18116220235236993
KLEEFSTRA SYNDROME	0.004851759000000001	0.18116220235236993
WITTEVEEN-KOLK SYNDROME	0.004851759000000001	0.18116220235236993
AICARDI-GOUTIÈRES SYNDROME	0.004851759000000001	0.18116220235236993
INFANTILE NEUROAXONAL DYSTROPHY	0.004851759000000001	0.18116220235236993
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.004851759000000001	0.18116220235236993
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.004851759000000001	0.18116220235236993
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.004851759000000001	0.18116220235236993
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.004851759000000001	0.18116220235236993
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.004851759000000001	0.18116220235236993
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004851759000000001	0.18116220235236993
AICARDI-GOUTIERES SYNDROME 7	0.004851759000000001	0.18116220235236993
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.004851759000000001	0.18116220235236993
ZTTK SYNDROME; ZTTKS	0.004851759000000001	0.18116220235236993
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.004851759000000001	0.18116220235236993
RING CHROMOSOME 22 SYNDROME	0.004851759000000001	0.18116220235236993
SCHIZOPHRENIA	0.0046729	0.174483698669367
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.0046729	0.174483698669367
BONNEMANN-MEINECKE-REICH SYNDROME	0.0046729	0.174483698669367
6Q16 MICRODELETION SYNDROME	0.0046729	0.174483698669367
ISAAC SYNDROME	0.0046729	0.174483698669367
ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES	0.0046729	0.174483698669367
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.0046729	0.174483698669367
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.0046729	0.174483698669367
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0046729	0.174483698669367
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.0046729	0.174483698669367
SACCHAROPINURIA	0.0046729	0.174483698669367
ELECTROENCEPHALOGRAPHIC PATTERNS	0.0046729	0.174483698669367
ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKEPHENOMENON	0.0046729	0.174483698669367
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0046729	0.174483698669367
ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS	0.0046729	0.174483698669367
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.0046729	0.174483698669367
CINCA SYNDROME	0.0046729	0.174483698669367
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0046729	0.174483698669367
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.0046729	0.174483698669367
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.0046729	0.174483698669367
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0046729	0.174483698669367
DYSTONIA 3, TORSION, X-LINKED	0.00465116	0.17367193817608187
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00465116	0.17367193817608187
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	0.00465116	0.17367193817608187
NYSTAGMUS, MYOCLONIC	0.00465116	0.17367193817608187
SPINOCEREBELLAR ATAXIA TYPE 37	0.00465116	0.17367193817608187
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.00465116	0.17367193817608187
PARKINSONIAN-PYRAMIDAL SYNDROME	0.00465116	0.17367193817608187
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.00465116	0.17367193817608187
DYSTONIA 11, MYOCLONIC	0.00465116	0.17367193817608187
FACIOMANDIBULAR MYOCLONUS, NOCTURNAL	0.00465116	0.17367193817608187
9P13 MICRODELETION SYNDROME	0.00465116	0.17367193817608187
ABETA AMYLOIDOSIS, IOWA TYPE	0.00465116	0.17367193817608187
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00465116	0.17367193817608187
HYPEREKPLEXIA 2; HKPX2	0.00465116	0.17367193817608187
X-LINKED DYSTONIA-PARKINSONISM	0.00465116	0.17367193817608187
CREUTZFELDT-JAKOB DISEASE; CJD	0.00465116	0.17367193817608187
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00465116	0.17367193817608187
RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	0.00465116	0.17367193817608187
DYSTONIA 15, MYOCLONIC; DYT15	0.00465116	0.17367193817608187
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00465116	0.17367193817608187
DYSTONIA 23; DYT23	0.00465116	0.17367193817608187
OROFACIODIGITAL SYNDROME III	0.00465116	0.17367193817608187
CARIBBEAN PARKINSONISM	0.00465116	0.17367193817608187
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.16094589349708305
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00431034	0.16094589349708305
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.16094589349708305
PANDAS	0.00431034	0.16094589349708305
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00431034	0.16094589349708305
DYSOSTEOSCLEROSIS	0.00431034	0.16094589349708305
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00431034	0.16094589349708305
TRISOMY 5P	0.00431034	0.16094589349708305
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00431034	0.16094589349708305
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00431034	0.16094589349708305
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00431034	0.16094589349708305
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00431034	0.16094589349708305
AICARDI-GOUTIERES SYNDROME 6	0.00431034	0.16094589349708305
DOWN SYNDROME	0.00431034	0.16094589349708305
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00431034	0.16094589349708305
HAMAMY SYNDROME; HMMS	0.00431034	0.16094589349708305
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00431034	0.16094589349708305
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.16094589349708305
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00431034	0.16094589349708305
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00431034	0.16094589349708305
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00431034	0.16094589349708305
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00431034	0.16094589349708305
DISTAL MONOSOMY 3P	0.0041910590000000005	0.15649200189636814
TRISOMY X	0.0041910590000000005	0.15649200189636814
PAPILLOMA OF CHOROID PLEXUS	0.0041910590000000005	0.15649200189636814
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.0041910590000000005	0.15649200189636814
ALG9-CDG	0.0041910590000000005	0.15649200189636814
ALG2-CDG	0.0041910590000000005	0.15649200189636814
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.0041910590000000005	0.15649200189636814
MPDU1-CDG	0.0041910590000000005	0.15649200189636814
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.0041910590000000005	0.15649200189636814
INCONTINENTIA PIGMENTI	0.0041910590000000005	0.15649200189636814
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.0041910590000000005	0.15649200189636814
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0041910590000000005	0.15649200189636814
ENDOCARDIAL FIBROELASTOSIS	0.0041910590000000005	0.15649200189636814
LYMPHANGIOLEIOMYOMATOSIS	0.0041910590000000005	0.15649200189636814
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.0041910590000000005	0.15649200189636814
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.0041910590000000005	0.15649200189636814
CONGENITAL TOXOPLASMOSIS	0.0041910590000000005	0.15649200189636814
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.0041910590000000005	0.15649200189636814
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.0041910590000000005	0.15649200189636814
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0041910590000000005	0.15649200189636814
FOIX-CHAVANY-MARIE SYNDROME	0.0041910590000000005	0.15649200189636814
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.0041910590000000005	0.15649200189636814
HOLOPROSENCEPHALY	0.0041910590000000005	0.15649200189636814
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.0041910590000000005	0.15649200189636814
BENIGN FAMILIAL NEONATAL EPILEPSY	0.0041910590000000005	0.15649200189636814
ONDINE SYNDROME	0.0041910590000000005	0.15649200189636814
HYPERLYSINEMIA, TYPE I	0.0041910590000000005	0.15649200189636814
MULTIPLE CARBOXYLASE DEFICIENCY	0.0041910590000000005	0.15649200189636814
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.0041910590000000005	0.15649200189636814
NOONAN SYNDROME 7; NS7	0.0041910590000000005	0.15649200189636814
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.0041910590000000005	0.15649200189636814
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0041910590000000005	0.15649200189636814
CRISPONI SYNDROME	0.0041910590000000005	0.15649200189636814
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.0041910590000000005	0.15649200189636814
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.0041910590000000005	0.15649200189636814
THANATOPHORIC DYSPLASIA TYPE 2	0.0041910590000000005	0.15649200189636814
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.0041910590000000005	0.15649200189636814
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.0041910590000000005	0.15649200189636814
PGM3-CDG	0.003704859	0.13833754229033202
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.0037048589999999996	0.138337542290332
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.0037048589999999996	0.138337542290332
PYRUVATE DEHYDROGENASE DEFICIENCY	0.0037048589999999996	0.138337542290332
FREE SIALIC ACID STORAGE DISEASE	0.0037048589999999996	0.138337542290332
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0037048589999999996	0.138337542290332
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.0037048589999999996	0.138337542290332
NIEMANN-PICK DISEASE, TYPE C2	0.0037048589999999996	0.138337542290332
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.0037048589999999996	0.138337542290332
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.0037048589999999996	0.138337542290332
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.0037048589999999996	0.138337542290332
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.0037048589999999996	0.138337542290332
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0037048589999999996	0.138337542290332
CAMOS SYNDROME	0.0037048589999999996	0.138337542290332
PELIZAEUS-MERZBACHER DISEASE	0.0037048589999999996	0.138337542290332
COCKAYNE SYNDROME A; CSA	0.0037048589999999996	0.138337542290332
SALLA DISEASE	0.0037048589999999996	0.138337542290332
CEREBELLOPARENCHYMAL DISORDER II	0.0037048589999999996	0.138337542290332
48,XXYY SYNDROME	0.0037048589999999996	0.138337542290332
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.0037048589999999996	0.138337542290332
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.0037048589999999996	0.138337542290332
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.0037048589999999996	0.138337542290332
CHROMOSOME 1P35 DELETION SYNDROME	0.0037048589999999996	0.138337542290332
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.0037048589999999996	0.138337542290332
METACHROMATIC LEUKODYSTROPHY	0.0037048589999999996	0.138337542290332
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0037048589999999996	0.138337542290332
LEIGH SYNDROME; LS	0.0037048589999999996	0.138337542290332
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0037048589999999996	0.138337542290332
LISSENCEPHALY, X-LINKED, 1; LISX1	0.0037048589999999996	0.138337542290332
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.0037048589999999996	0.138337542290332
OCULODENTODIGITAL DYSPLASIA	0.0037048589999999996	0.138337542290332
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.0037048589999999996	0.138337542290332
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.0037048589999999996	0.138337542290332
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.0037048589999999996	0.138337542290332
KALLMANN SYNDROME	0.0037048589999999996	0.138337542290332
PRUNE BELLY SYNDROME	0.00364964	0.13627569304108125
REACTIVE ARTHRITIS	0.00364964	0.13627569304108125
TRISOMY 18	0.00364964	0.13627569304108125
LEPRECHAUNISM	0.00364964	0.13627569304108125
SCHIZOPHRENIA 19; SCZD19	0.00364964	0.13627569304108125
FOCAL DERMAL HYPOPLASIA	0.00364964	0.13627569304108125
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00364964	0.13627569304108125
TETRASOMY X	0.00364964	0.13627569304108125
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00364964	0.13627569304108125
VOGT-KOYANAGI-HARADA DISEASE	0.00364964	0.13627569304108125
DEAFNESS-HYPOGONADISM SYNDROME	0.00364964	0.13627569304108125
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.00364964	0.13627569304108125
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00364964	0.13627569304108125
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.00364964	0.13627569304108125
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00364964	0.13627569304108125
VASCULAR EHLERS-DANLOS SYNDROME	0.00364964	0.13627569304108125
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00364964	0.13627569304108125
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00364964	0.13627569304108125
MUCOLIPIDOSIS TYPE III	0.00364964	0.13627569304108125
MONILETHRIX	0.00364964	0.13627569304108125
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00364964	0.13627569304108125
BARDET-BIEDL SYNDROME 18; BBS18	0.00364964	0.13627569304108125
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00364964	0.13627569304108125
BARDET-BIEDL SYNDROME 17; BBS17	0.00364964	0.13627569304108125
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00364964	0.13627569304108125
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00364964	0.13627569304108125
BARDET-BIEDL SYNDROME 16; BBS16	0.00364964	0.13627569304108125
CLASSICAL EHLERS-DANLOS SYNDROME	0.00364964	0.13627569304108125
ALPHA-THALASSEMIA	0.00364964	0.13627569304108125
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00364964	0.13627569304108125
BARDET-BIEDL SYNDROME 12; BBS12	0.00364964	0.13627569304108125
BARDET-BIEDL SYNDROME 10; BBS10	0.00364964	0.13627569304108125
BARDET-BIEDL SYNDROME 8; BBS8	0.00364964	0.13627569304108125
BARDET-BIEDL SYNDROME 5; BBS5	0.00364964	0.13627569304108125
JOUBERT SYNDROME 31; JBTS31	0.00364964	0.13627569304108125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00364964	0.13627569304108125
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00364964	0.13627569304108125
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00364964	0.13627569304108125
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00364964	0.13627569304108125
ISOLATED CLOVERLEAF SKULL SYNDROME	0.00364964	0.13627569304108125
ISOLATED KLIPPEL-FEIL SYNDROME	0.00364964	0.13627569304108125
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00364964	0.13627569304108125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.00364964	0.13627569304108125
SCLEROSTEOSIS 1; SOST1	0.00364964	0.13627569304108125
RHIZOMELIC SYNDROME, URBACH TYPE	0.00364964	0.13627569304108125
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.00364964	0.13627569304108125
LAMELLAR ICHTHYOSIS	0.00364964	0.13627569304108125
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00364964	0.13627569304108125
DUCHENNE MUSCULAR DYSTROPHY	0.00364964	0.13627569304108125
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00364964	0.13627569304108125
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00364964	0.13627569304108125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00364964	0.13627569304108125
LYSINURIC PROTEIN INTOLERANCE	0.00364964	0.13627569304108125
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00364964	0.13627569304108125
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00364964	0.13627569304108125
RIN2 SYNDROME	0.00364964	0.13627569304108125
PACHYONYCHIA CONGENITA	0.00364964	0.13627569304108125
DK1-CDG	0.00364964	0.13627569304108125
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00364964	0.13627569304108125
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00364964	0.13627569304108125
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00364964	0.13627569304108125
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00364964	0.13627569304108125
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00364964	0.13627569304108125
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.00364964	0.13627569304108125
MONOAMINE OXIDASE A DEFICIENCY	0.00364964	0.13627569304108125
FLOATING-HARBOR SYNDROME	0.00364964	0.13627569304108125
KERATODERMA HEREDITARIUM MUTILANS	0.00364964	0.13627569304108125
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00364964	0.13627569304108125
EARLY-ONSET SCHIZOPHRENIA	0.00364964	0.13627569304108125
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00364964	0.13627569304108125
CONGENITAL SHORT BOWEL SYNDROME	0.00364964	0.13627569304108125
ISOTRETINOIN SYNDROME	0.00364964	0.13627569304108125
RING CHROMOSOME 1 SYNDROME	0.00364964	0.13627569304108125
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.00364964	0.13627569304108125
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00364964	0.13627569304108125
NON-DISTAL TRISOMY 10Q	0.00364964	0.13627569304108125
SECKEL SYNDROME	0.00364964	0.13627569304108125
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00364964	0.13627569304108125
PYCNODYSOSTOSIS	0.00364964	0.13627569304108125
KEIPERT SYNDROME	0.00364964	0.13627569304108125
COWCHOCK SYNDROME; COWCK	0.00364964	0.13627569304108125
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00364964	0.13627569304108125
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00364964	0.13627569304108125
TRICHOHEPATOENTERIC SYNDROME 1	0.00364964	0.13627569304108125
NON-DISTAL TRISOMY 13Q	0.00364964	0.13627569304108125
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	0.13627569304108125
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00364964	0.13627569304108125
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00364964	0.13627569304108125
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00364964	0.13627569304108125
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00364964	0.13627569304108125
ALG12-CDG	0.00364964	0.13627569304108125
AARSKOG-SCOTT SYNDROME	0.00364964	0.13627569304108125
MALARIA	0.00364964	0.13627569304108125
DISTAL MONOSOMY 13Q	0.00364964	0.13627569304108125
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00364964	0.13627569304108125
TRISOMY 4P	0.00364964	0.13627569304108125
SPINOCEREBELLAR ATAXIA TYPE 32	0.00364964	0.13627569304108125
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00364964	0.13627569304108125
DISTAL TRISOMY 18Q	0.00364964	0.13627569304108125
DISTAL TRISOMY 14Q	0.00364964	0.13627569304108125
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00364964	0.13627569304108125
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.00364964	0.13627569304108125
FETAL ALCOHOL SYNDROME	0.00364964	0.13627569304108125
ISOLATED ECTOPIA LENTIS	0.00364964	0.13627569304108125
HIDROTIC ECTODERMAL DYSPLASIA	0.00364964	0.13627569304108125
SECKEL SYNDROME 4	0.00364964	0.13627569304108125
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.00364964	0.13627569304108125
MEDULLOBLASTOMA	0.00364964	0.13627569304108125
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.00364964	0.13627569304108125
ALLAN-HERNDON-DUDLEY SYNDROME	0.00316344	0.11812123343504513
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00316344	0.11812123343504513
JOUBERT SYNDROME 32; JBTS32	0.00316344	0.11812123343504513
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.00316344	0.11812123343504513
SPASTIC PARAPLEGIA TYPE 2	0.00316344	0.11812123343504513
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.00316344	0.11812123343504513
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00316344	0.11812123343504513
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00316344	0.11812123343504513
MARINESCO-SJÖGREN SYNDROME	0.00316344	0.11812123343504513
SANDHOFF DISEASE	0.00316344	0.11812123343504513
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00316344	0.11812123343504513
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00316344	0.11812123343504513
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.00316344	0.11812123343504513
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00316344	0.11812123343504513
ACERULOPLASMINEMIA	0.00316344	0.11812123343504513
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00316344	0.11812123343504513
FAMILIAL PAROXYSMAL ATAXIA	0.00316344	0.11812123343504513
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.00316344	0.11812123343504513
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00316344	0.11812123343504513
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00316344	0.11812123343504513
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00316344	0.11812123343504513
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.00316344	0.11812123343504513
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.00316344	0.11812123343504513
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00316344	0.11812123343504513
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00316344	0.11812123343504513
PELLAGRA-LIKE SYNDROME	0.00316344	0.11812123343504513
ACERULOPLASMINEMIA	0.00316344	0.11812123343504513
SPINOCEREBELLAR ATAXIA 30; SCA30	0.00316344	0.11812123343504513
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.00316344	0.11812123343504513
EPISODIC ATAXIA, TYPE 8	0.00316344	0.11812123343504513
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00316344	0.11812123343504513
CLASSIC GALACTOSEMIA	0.00316344	0.11812123343504513
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00316344	0.11812123343504513
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00316344	0.11812123343504513
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.00316344	0.11812123343504513
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.00316344	0.11812123343504513
AGEL AMYLOIDOSIS	0.00316344	0.11812123343504513
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00316344	0.11812123343504513
MACHADO-JOSEPH DISEASE; MJD	0.00316344	0.11812123343504513
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00316344	0.11812123343504513
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.00316344	0.11812123343504513
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00316344	0.11812123343504513
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00316344	0.11812123343504513
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00316344	0.11812123343504513
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00316344	0.11812123343504513
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00316344	0.11812123343504513
SPINOCEREBELLAR ATAXIA 31	0.00316344	0.11812123343504513
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00316344	0.11812123343504513
ERDHEIM-CHESTER DISEASE	0.00316344	0.11812123343504513
MARINESCO-SJOGREN SYNDROME; MSS	0.00316344	0.11812123343504513
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.00316344	0.11812123343504513
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.00316344	0.11812123343504513
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00316344	0.11812123343504513
SPINOCEREBELLAR ATAXIA TYPE 4	0.00316344	0.11812123343504513
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.00316344	0.11812123343504513
PEROXISOME BIOGENESIS DISORDER 6B	0.00316344	0.11812123343504513
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.002227759	0.08318338292365991
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.002227759	0.08318338292365991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.002227759	0.08318338292365991
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.002227759	0.08318338292365991
OCULOCEREBROCUTANEOUS SYNDROME	0.002227759	0.08318338292365991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002227759	0.08318338292365991
WEAVER SYNDROME	0.002227759	0.08318338292365991
SPINOCEREBELLAR ATAXIA 47; SCA47	0.002227759	0.08318338292365991
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.002227759	0.08318338292365991
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.002227759	0.08318338292365991
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.002227759	0.08318338292365991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.002227759	0.08318338292365991
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.002227759	0.08318338292365991
FAMILIAL THROMBOCYTOSIS	0.002227759	0.08318338292365991
RAPID-ONSET DYSTONIA-PARKINSONISM	0.002227759	0.08318338292365991
EPISODIC ATAXIA, TYPE 6	0.002227759	0.08318338292365991
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.002227759	0.08318338292365991
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.002227759	0.08318338292365991
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.002227759	0.08318338292365991
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.002227759	0.08318338292365991
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002227759	0.08318338292365991
MYASTHENIA GRAVIS	0.002227759	0.08318338292365991
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.002227759	0.08318338292365991
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.002227759	0.08318338292365991
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.002227759	0.08318338292365991
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.002227759	0.08318338292365991
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.002227759	0.08318338292365991
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.002227759	0.08318338292365991
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.002227759	0.08318338292365991
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.002227759	0.08318338292365991
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.002227759	0.08318338292365991
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.002227759	0.08318338292365991
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.002227759	0.08318338292365991
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.002227759	0.08318338292365991
SNEDDON SYNDROME	0.002227759	0.08318338292365991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.002227759	0.08318338292365991
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.002227759	0.08318338292365991
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.002227759	0.08318338292365991
SJÖGREN-LARSSON SYNDROME	0.002227759	0.08318338292365991
WYBURN-MASON SYNDROME	0.002227759	0.08318338292365991
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.002227759	0.08318338292365991
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.002227759	0.08318338292365991
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.002227759	0.08318338292365991
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.002227759	0.08318338292365991
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.002018519	0.07537046822195895
LHERMITTE-DUCLOS DISEASE	0.002018519	0.07537046822195895
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.002018519	0.07537046822195895
GM1 GANGLIOSIDOSIS	0.002018519	0.07537046822195895
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.002018519	0.07537046822195895
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.002018519	0.07537046822195895
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.002018519	0.07537046822195895
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.002018519	0.07537046822195895
SRD5A3-CDG	0.002018519	0.07537046822195895
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.002018519	0.07537046822195895
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.002018519	0.07537046822195895
CITRULLINEMIA TYPE I	0.002018519	0.07537046822195895
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.002018519	0.07537046822195895
CEDNIK SYNDROME	0.002018519	0.07537046822195895
GRISCELLI SYNDROME	0.002018519	0.07537046822195895
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.002018519	0.07537046822195895
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.002018519	0.07537046822195895
RFT1-CDG	0.002018519	0.07537046822195895
EAST SYNDROME	0.002018519	0.07537046822195895
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.002018519	0.07537046822195895
OROFACIODIGITAL SYNDROME TYPE 1	0.002018519	0.07537046822195895
JOUBERT SYNDROME	0.002018519	0.07537046822195895
2Q23.1 MICRODELETION SYNDROME	0.002018519	0.07537046822195895
CONGENITAL MYASTHENIC SYNDROME	0.002018519	0.07537046822195895
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.002018519	0.07537046822195895
BETA-KETOTHIOLASE DEFICIENCY	0.002018519	0.07537046822195895
MEVALONIC ACIDURIA	0.002018519	0.07537046822195895
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.002018519	0.07537046822195895
INFANTILE REFSUM DISEASE	0.002018519	0.07537046822195895
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.002018519	0.07537046822195895
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.002018519	0.07537046822195895
DYSEQUILIBRIUM SYNDROME	0.002018519	0.07537046822195895
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.002018519	0.07537046822195895
FAMILIAL DYSAUTONOMIA	0.002018519	0.07537046822195895
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.002018519	0.07537046822195895
OROFACIODIGITAL SYNDROME TYPE 6	0.002018519	0.07537046822195895
PMM2-CDG	0.002018519	0.07537046822195895
JOUBERT SYNDROME WITH OCULAR DEFECT	0.002018519	0.07537046822195895
SPONTANEOUS PERIODIC HYPOTHERMIA	0.002018519	0.07537046822195895
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.002018519	0.07537046822195895
EPISODIC ATAXIA TYPE 6	0.002018519	0.07537046822195895
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.002018519	0.07537046822195895
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.002018519	0.07537046822195895
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.002018519	0.07537046822195895
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.002018519	0.07537046822195895
MAPLE SYRUP URINE DISEASE	0.002018519	0.07537046822195895
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.002018519	0.07537046822195895
SIALIDOSIS TYPE 2	0.002018519	0.07537046822195895
15Q11Q13 MICRODUPLICATION SYNDROME	0.002018519	0.07537046822195895
ALG11-CDG	0.002018519	0.07537046822195895
JOUBERT SYNDROME WITH RENAL DEFECT	0.002018519	0.07537046822195895
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.002018519	0.07537046822195895
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002018519	0.07537046822195895
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.002018519	0.07537046822195895
ATYPICAL TERATOID RHABDOID TUMOR	0.002018519	0.07537046822195895
COACH SYNDROME	0.002018519	0.07537046822195895
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.002018519	0.07537046822195895
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.002018519	0.07537046822195895
MYHRE SYNDROME	0.002018519	0.07537046822195895
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.002018519	0.07537046822195895
FLYNN-AIRD SYNDROME	0.002018519	0.07537046822195895
ARGININOSUCCINIC ACIDURIA	0.002018519	0.07537046822195895
KNOBLOCH SYNDROME 1; KNO1	0.002018519	0.07537046822195895
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.002018519	0.07537046822195895
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.002018519	0.07537046822195895
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002018519	0.07537046822195895
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.002018519	0.07537046822195895
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.002018519	0.07537046822195895
FOLATE MALABSORPTION, HEREDITARY	0.002018519	0.07537046822195895
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.002018519	0.07537046822195895
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.002018519	0.07537046822195895
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.002018519	0.07537046822195895
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.002018519	0.07537046822195895
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.002018519	0.07537046822195895
ELEJALDE DISEASE	0.002018519	0.07537046822195895
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002018519	0.07537046822195895
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.002018519	0.07537046822195895
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.002018519	0.07537046822195895
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.002018519	0.07537046822195895
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.002018519	0.07537046822195895
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.002018519	0.07537046822195895
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.002018519	0.07537046822195895
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.002018519	0.07537046822195895
SULFOCYSTEINURIA	0.002018519	0.07537046822195895
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.002018519	0.07537046822195895
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.002018519	0.07537046822195895
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002018519	0.07537046822195895
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.002018519	0.07537046822195895
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.002018519	0.07537046822195895
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.002018519	0.07537046822195895
MAPLE SYRUP URINE DISEASE; MSUD	0.002018519	0.07537046822195895
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.002018519	0.07537046822195895
MEGALENCEPHALY WITH DYSMYELINATION	0.002018519	0.07537046822195895
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.002018519	0.07537046822195895
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.002018519	0.07537046822195895
LISSENCEPHALY 3; LIS3	0.002018519	0.07537046822195895
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002018519	0.07537046822195895
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.002018519	0.07537046822195895
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.002018519	0.07537046822195895
PERRAULT SYNDROME 5; PRLTS5	0.002018519	0.07537046822195895
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.002018519	0.07537046822195895
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.002018519	0.07537046822195895
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.002018519	0.07537046822195895
CITRULLINEMIA, CLASSIC	0.002018519	0.07537046822195895
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.002018519	0.07537046822195895
KEARNS-SAYRE SYNDROME; KSS	0.002018519	0.07537046822195895
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.002018519	0.07537046822195895
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.002018519	0.07537046822195895
NEUROFIBROMATOSIS, TYPE II	0.002018519	0.07537046822195895
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.002018519	0.07537046822195895
GITELMAN SYNDROME	0.002018519	0.07537046822195895
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.002018519	0.07537046822195895
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.002018519	0.07537046822195895
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.002018519	0.07537046822195895
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.002018519	0.07537046822195895
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.002018519	0.07537046822195895
DIAMINOPENTANURIA	0.002018519	0.07537046822195895
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.002018519	0.07537046822195895
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.002018519	0.07537046822195895
SPINOCEREBELLAR ATAXIA 40; SCA40	0.00168634	0.06296707406837303
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00168634	0.06296707406837303
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00168634	0.06296707406837303
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00168634	0.06296707406837303
SYRINGOMYELIA, ISOLATED	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 34	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.00168634	0.06296707406837303
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00168634	0.06296707406837303
POSTPOLIOMYELITIS SYNDROME	0.00168634	0.06296707406837303
TREMOR, HEREDITARY ESSENTIAL, 1	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.00168634	0.06296707406837303
LESCH-NYHAN SYNDROME; LNS	0.00168634	0.06296707406837303
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00168634	0.06296707406837303
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 31	0.00168634	0.06296707406837303
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE	0.00168634	0.06296707406837303
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00168634	0.06296707406837303
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00168634	0.06296707406837303
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 20	0.00168634	0.06296707406837303
HUNTINGTON DISEASE-LIKE 1	0.00168634	0.06296707406837303
EPISODIC ATAXIA TYPE 5	0.00168634	0.06296707406837303
WILSON DISEASE	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 30	0.00168634	0.06296707406837303
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00168634	0.06296707406837303
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.00168634	0.06296707406837303
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00168634	0.06296707406837303
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00168634	0.06296707406837303
DYSTONIA 16	0.00168634	0.06296707406837303
UROCANIC ACIDURIA	0.00168634	0.06296707406837303
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00168634	0.06296707406837303
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00168634	0.06296707406837303
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00168634	0.06296707406837303
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00168634	0.06296707406837303
PARKINSON DISEASE, LATE-ONSET; PD	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00168634	0.06296707406837303
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00168634	0.06296707406837303
PERRY SYNDROME	0.00168634	0.06296707406837303
ACHONDROPLASIA	0.00168634	0.06296707406837303
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00168634	0.06296707406837303
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.00168634	0.06296707406837303
WOODHOUSE-SAKATI SYNDROME	0.00168634	0.06296707406837303
NOONAN SYNDROME	0.00168634	0.06296707406837303
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.00168634	0.06296707406837303
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00168634	0.06296707406837303
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.00168634	0.06296707406837303
HUNTINGTON DISEASE-LIKE 2	0.00168634	0.06296707406837303
WOUND BOTULISM	0.00168634	0.06296707406837303
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00168634	0.06296707406837303
INFANT BOTULISM	0.00168634	0.06296707406837303
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00168634	0.06296707406837303
INTESTINAL BOTULISM	0.00168634	0.06296707406837303
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 42	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 15	0.00168634	0.06296707406837303
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00168634	0.06296707406837303
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00168634	0.06296707406837303
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00168634	0.06296707406837303
FOODBORNE BOTULISM	0.00168634	0.06296707406837303
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00168634	0.06296707406837303
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00168634	0.06296707406837303
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00168634	0.06296707406837303
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00168634	0.06296707406837303
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.00168634	0.06296707406837303
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00168634	0.06296707406837303
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.00168634	0.06296707406837303
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00168634	0.06296707406837303
WILSON DISEASE	0.00168634	0.06296707406837303
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 12	0.00168634	0.06296707406837303
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.00168634	0.06296707406837303
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00168634	0.06296707406837303
SYDENHAM CHOREA	0.00168634	0.06296707406837303
NATIVE AMERICAN MYOPATHY	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00168634	0.06296707406837303
PEROXISOME BIOGENESIS DISORDER 5B	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00168634	0.06296707406837303
UNVERRICHT-LUNDBORG DISEASE	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 13	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 40	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 14	0.00168634	0.06296707406837303
OPTIC ATROPHY 2	0.00168634	0.06296707406837303
FACIAL ONSET SENSORY AND MOTOR NEURONOPATHY	0.00168634	0.06296707406837303
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 38	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 26	0.00168634	0.06296707406837303
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.00168634	0.06296707406837303
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00168634	0.06296707406837303
EPISODIC ATAXIA, TYPE 5	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00168634	0.06296707406837303
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 23	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 28	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 20	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 26	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00168634	0.06296707406837303
DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	0.00168634	0.06296707406837303
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00168634	0.06296707406837303
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00168634	0.06296707406837303
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.00168634	0.06296707406837303
TURNPENNY-FRY SYNDROME; TPFS	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00168634	0.06296707406837303
MULTIPLE SYSTEM ATROPHY	0.00168634	0.06296707406837303
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00168634	0.06296707406837303
KENNEDY DISEASE	0.00168634	0.06296707406837303
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA-PRECOCIOUS PUBERTY SYNDROME	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00168634	0.06296707406837303
EPISODIC ATAXIA, TYPE 7; EA7	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 6	0.00168634	0.06296707406837303
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00168634	0.06296707406837303
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00168634	0.06296707406837303
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.00168634	0.06296707406837303
PRIMARY DYSTONIA, DYT6 TYPE	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 2	0.00168634	0.06296707406837303
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 1	0.00168634	0.06296707406837303
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00168634	0.06296707406837303
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 27	0.00168634	0.06296707406837303
MYASTHENIA GRAVIS; MG	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.00168634	0.06296707406837303
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00168634	0.06296707406837303
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.00168634	0.06296707406837303
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00168634	0.06296707406837303
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00168634	0.06296707406837303
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00168634	0.06296707406837303
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00168634	0.06296707406837303
DYSTONIA 12; DYT12	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 11	0.00168634	0.06296707406837303
PRIMARY DYSTONIA, DYT17 TYPE	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 18	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.00168634	0.06296707406837303
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00168634	0.06296707406837303
EPISODIC ATAXIA TYPE 1	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00168634	0.06296707406837303
CHIARI MALFORMATION TYPE I	0.00168634	0.06296707406837303
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.00168634	0.06296707406837303
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00168634	0.06296707406837303
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00168634	0.06296707406837303
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 36	0.00168634	0.06296707406837303
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.00168634	0.06296707406837303
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00168634	0.06296707406837303
LEBER OPTIC ATROPHY AND DYSTONIA	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.00168634	0.06296707406837303
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00168634	0.06296707406837303
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.00168634	0.06296707406837303
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00168634	0.06296707406837303
MOEBIUS SYNDROME; MBS	0.00168634	0.06296707406837303
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00168634	0.06296707406837303
EPISODIC ATAXIA, TYPE 1; EA1	0.00168634	0.06296707406837303
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00168634	0.06296707406837303
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00168634	0.06296707406837303
MACHADO-JOSEPH DISEASE TYPE 1	0.00168634	0.06296707406837303
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00168634	0.06296707406837303
MACHADO-JOSEPH DISEASE TYPE 2	0.00168634	0.06296707406837303
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.00168634	0.06296707406837303
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00168634	0.06296707406837303
MACHADO-JOSEPH DISEASE TYPE 3	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 43	0.00168634	0.06296707406837303
PURE MITOCHONDRIAL MYOPATHY	0.00168634	0.06296707406837303
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00168634	0.06296707406837303
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.00168634	0.06296707406837303
JUVENILE DERMATOMYOSITIS	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 3	0.00168634	0.06296707406837303
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA TYPE 7	0.00168634	0.06296707406837303
MAST SYNDROME	0.00168634	0.06296707406837303
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00168634	0.06296707406837303
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.00168634	0.06296707406837303
CEREBELLAR ATAXIA, CAYMAN TYPE	0.00168634	0.06296707406837303
MYOPATHY AND DIABETES MELLITUS	0.00168634	0.06296707406837303
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00168634	0.06296707406837303
DISTAL MYOTILINOPATHY	0.00168634	0.06296707406837303
BOTULISM	0.00168634	0.06296707406837303
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00168634	0.06296707406837303
POSTORGASMIC ILLNESS SYNDROME	0.00168634	0.06296707406837303
SPASTIC PARAPLEGIA TYPE 7	0.00168634	0.06296707406837303
FRIEDREICH ATAXIA	0.00168634	0.06296707406837303
WOODHOUSE-SAKATI SYNDROME	0.00168634	0.06296707406837303
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00168634	0.06296707406837303
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.00168634	0.06296707406837303
OROMANDIBULAR DYSTONIA	0.00168634	0.06296707406837303
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.00168634	0.06296707406837303
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.00168634	0.06296707406837303
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00168634	0.06296707406837303
PRIMARY DYSTONIA, DYT2 TYPE	0.00168634	0.06296707406837303
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00168634	0.06296707406837303
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00168634	0.06296707406837303
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.00168634	0.06296707406837303
EPISODIC ATAXIA, TYPE 2	0.00168634	0.06296707406837303
CENTRAL NEUROCYTOMA	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 21	0.0014770999999999999	0.05515415936667208
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0014770999999999999	0.05515415936667208
NAVAJO NEUROHEPATOPATHY	0.0014770999999999999	0.05515415936667208
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0014770999999999999	0.05515415936667208
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.0014770999999999999	0.05515415936667208
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05515415936667208
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0014770999999999999	0.05515415936667208
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.0014770999999999999	0.05515415936667208
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0014770999999999999	0.05515415936667208
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0014770999999999999	0.05515415936667208
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0014770999999999999	0.05515415936667208
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0014770999999999999	0.05515415936667208
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0014770999999999999	0.05515415936667208
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0014770999999999999	0.05515415936667208
NEUROFIBROMATOSIS TYPE 2	0.0014770999999999999	0.05515415936667208
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.0014770999999999999	0.05515415936667208
POSTERIOR CORTICAL ATROPHY	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 17; JBTS17	0.0014770999999999999	0.05515415936667208
TRYPTOPHANURIA WITH DWARFISM	0.0014770999999999999	0.05515415936667208
CHANARIN-DORFMAN SYNDROME	0.0014770999999999999	0.05515415936667208
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0014770999999999999	0.05515415936667208
LEGIONELLOSIS	0.0014770999999999999	0.05515415936667208
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.0014770999999999999	0.05515415936667208
PIEBALDISM	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 6	0.0014770999999999999	0.05515415936667208
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.0014770999999999999	0.05515415936667208
RHOMBENCEPHALOSYNAPSIS	0.0014770999999999999	0.05515415936667208
ALLAN-HERNDON-DUDLEY SYNDROME	0.0014770999999999999	0.05515415936667208
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 14	0.0014770999999999999	0.05515415936667208
ARIMA SYNDROME	0.0014770999999999999	0.05515415936667208
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0014770999999999999	0.05515415936667208
EPISODIC ATAXIA TYPE 4	0.0014770999999999999	0.05515415936667208
245800 LAURENCE-MOON SYNDROME	0.0014770999999999999	0.05515415936667208
KURU, SUSCEPTIBILITY TO	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 15	0.0014770999999999999	0.05515415936667208
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 7	0.0014770999999999999	0.05515415936667208
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0014770999999999999	0.05515415936667208
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0014770999999999999	0.05515415936667208
HEREDITARY SPASTIC PARAPLEGIA	0.0014770999999999999	0.05515415936667208
REFSUM DISEASE	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 8	0.0014770999999999999	0.05515415936667208
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0014770999999999999	0.05515415936667208
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.0014770999999999999	0.05515415936667208
USHER SYNDROME TYPE 1	0.0014770999999999999	0.05515415936667208
USHER SYNDROME TYPE 2	0.0014770999999999999	0.05515415936667208
USHER SYNDROME TYPE 3	0.0014770999999999999	0.05515415936667208
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0014770999999999999	0.05515415936667208
DE SANCTIS-CACCHIONE SYNDROME	0.0014770999999999999	0.05515415936667208
KIKUCHI-FUJIMOTO DISEASE	0.0014770999999999999	0.05515415936667208
REVESZ SYNDROME	0.0014770999999999999	0.05515415936667208
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0014770999999999999	0.05515415936667208
KEARNS-SAYRE SYNDROME	0.0014770999999999999	0.05515415936667208
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0014770999999999999	0.05515415936667208
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 5	0.0014770999999999999	0.05515415936667208
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0014770999999999999	0.05515415936667208
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0014770999999999999	0.05515415936667208
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0014770999999999999	0.05515415936667208
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0014770999999999999	0.05515415936667208
PITUITARY CARCINOMA	0.0014770999999999999	0.05515415936667208
WERNICKE-KORSAKOFF SYNDROME	0.0014770999999999999	0.05515415936667208
WAARDENBURG-SHAH SYNDROME	0.0014770999999999999	0.05515415936667208
46,XX GONADAL DYSGENESIS	0.0014770999999999999	0.05515415936667208
RICHARDS-RUNDLE SYNDROME; RRNS	0.0014770999999999999	0.05515415936667208
LAURENCE-MOON SYNDROME	0.0014770999999999999	0.05515415936667208
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0014770999999999999	0.05515415936667208
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.0014770999999999999	0.05515415936667208
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.0014770999999999999	0.05515415936667208
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0014770999999999999	0.05515415936667208
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0014770999999999999	0.05515415936667208
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0014770999999999999	0.05515415936667208
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0014770999999999999	0.05515415936667208
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.0014770999999999999	0.05515415936667208
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05515415936667208
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.0014770999999999999	0.05515415936667208
CLASSIC HODGKIN LYMPHOMA	0.0014770999999999999	0.05515415936667208
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0014770999999999999	0.05515415936667208
LEBER HEREDITARY OPTIC NEUROPATHY	0.0014770999999999999	0.05515415936667208
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0014770999999999999	0.05515415936667208
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 33; JBTS33	0.0014770999999999999	0.05515415936667208
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 25	0.0014770999999999999	0.05515415936667208
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0014770999999999999	0.05515415936667208
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0014770999999999999	0.05515415936667208
RIDDLE SYNDROME	0.0014770999999999999	0.05515415936667208
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0014770999999999999	0.05515415936667208
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.0014770999999999999	0.05515415936667208
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.0014770999999999999	0.05515415936667208
GILLESPIE SYNDROME; GLSP	0.0014770999999999999	0.05515415936667208
CHIARI MALFORMATION TYPE II	0.0014770999999999999	0.05515415936667208
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0014770999999999999	0.05515415936667208
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05515415936667208
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0014770999999999999	0.05515415936667208
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0014770999999999999	0.05515415936667208
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.0014770999999999999	0.05515415936667208
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0014770999999999999	0.05515415936667208
POSTERIOR COLUMN ATAXIA	0.0014770999999999999	0.05515415936667208
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0014770999999999999	0.05515415936667208
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0014770999999999999	0.05515415936667208
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0014770999999999999	0.05515415936667208
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0014770999999999999	0.05515415936667208
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0014770999999999999	0.05515415936667208
NYSTAGMUS, HEREDITARY VERTICAL	0.0014770999999999999	0.05515415936667208
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.0014770999999999999	0.05515415936667208
RICHARDS-RUNDLE SYNDROME	0.0014770999999999999	0.05515415936667208
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05515415936667208
CHAND SYNDROME	0.0014770999999999999	0.05515415936667208
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0014770999999999999	0.05515415936667208
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05515415936667208
GIANT CELL ARTERITIS	0.0014770999999999999	0.05515415936667208
OPTIC ATROPHY 1; OPA1	0.0014770999999999999	0.05515415936667208
WALDENSTRÖM MACROGLOBULINEMIA	0.0014770999999999999	0.05515415936667208
HOYERAAL-HREIDARSSON SYNDROME	0.0014770999999999999	0.05515415936667208
MECKEL SYNDROME 13; MKS13	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 28	0.0014770999999999999	0.05515415936667208
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 27	0.0014770999999999999	0.05515415936667208
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0014770999999999999	0.05515415936667208
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.0014770999999999999	0.05515415936667208
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.0014770999999999999	0.05515415936667208
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0014770999999999999	0.05515415936667208
ATAXIA-HYPOGONADISM-CHOROIDAL DYSTROPHY SYNDROME	0.0014770999999999999	0.05515415936667208
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0014770999999999999	0.05515415936667208
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.0014770999999999999	0.05515415936667208
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0014770999999999999	0.05515415936667208
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0014770999999999999	0.05515415936667208
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0014770999999999999	0.05515415936667208
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.0014770999999999999	0.05515415936667208
DEMENTIA, FAMILIAL DANISH	0.0014770999999999999	0.05515415936667208
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05515415936667208
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05515415936667208
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0014770999999999999	0.05515415936667208
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0014770999999999999	0.05515415936667208
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0014770999999999999	0.05515415936667208
CEREBELLAR HYPOPLASIA	0.0014770999999999999	0.05515415936667208
ATAXIA WITH FASCICULATIONS	0.0014770999999999999	0.05515415936667208
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0014770999999999999	0.05515415936667208
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0014770999999999999	0.05515415936667208
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 1	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 2	0.0014770999999999999	0.05515415936667208
SENIOR-LOKEN SYNDROME	0.0014770999999999999	0.05515415936667208
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.0014770999999999999	0.05515415936667208
ADULT POLYGLUCOSAN BODY DISEASE	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 35; JBTS35	0.0014770999999999999	0.05515415936667208
GEMIGNANI SYNDROME	0.0014770999999999999	0.05515415936667208
CEREBROFACIOARTICULAR SYNDROME	0.0014770999999999999	0.05515415936667208
TYPHOID	0.0014770999999999999	0.05515415936667208
TURCOT SYNDROME WITH POLYPOSIS	0.0014770999999999999	0.05515415936667208
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0014770999999999999	0.05515415936667208
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.0014770999999999999	0.05515415936667208
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0014770999999999999	0.05515415936667208
RAVINE SYNDROME	0.0014770999999999999	0.05515415936667208
BOUCHER-NEUHAUSER SYNDROME	0.0014770999999999999	0.05515415936667208
JOUBERT SYNDROME 3; JBTS3	0.0014770999999999999	0.05515415936667208
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0014770999999999999	0.05515415936667208
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05515415936667208
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0014770999999999999	0.05515415936667208
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0014770999999999999	0.05515415936667208
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0014770999999999999	0.05515415936667208
HODGKIN LYMPHOMA	0.0014770999999999999	0.05515415936667208
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.0014770999999999999	0.05515415936667208
SPINOCEREBELLAR ATAXIA TYPE 17	0.0014770999999999999	0.05515415936667208
HEREDITARY SPHEROCYTOSIS	0.0014770999999999999	0.05515415936667208
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0014770999999999999	0.05515415936667208
STIMMLER SYNDROME	0.0014770999999999999	0.05515415936667208
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0014770999999999999	0.05515415936667208
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.02021630885528687
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.02021630885528687
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000541419	0.02021630885528687
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.000541419	0.02021630885528687
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.000541419	0.02021630885528687
PRADER-WILLI-LIKE SYNDROME	0.000541419	0.02021630885528687
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.02021630885528687
GLYCEROL KINASE DEFICIENCY; GKD	0.000541419	0.02021630885528687
MENKES DISEASE	0.000541419	0.02021630885528687
HHHH SYNDROME	0.000541419	0.02021630885528687
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000541419	0.02021630885528687
PETTIGREW SYNDROME	0.000541419	0.02021630885528687
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.000541419	0.02021630885528687
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.02021630885528687
RENPENNING SYNDROME 1; RENS1	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED 9	0.000541419	0.02021630885528687
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.02021630885528687
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.02021630885528687
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.02021630885528687
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.02021630885528687
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.02021630885528687
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.02021630885528687
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.02021630885528687
INFANTILE SIALIC ACID STORAGE DISEASE	0.000541419	0.02021630885528687
STT3A-CDG	0.000541419	0.02021630885528687
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.02021630885528687
PYRUVATE CARBOXYLASE DEFICIENCY	0.000541419	0.02021630885528687
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.000541419	0.02021630885528687
INCONTINENTIA PIGMENTI; IP	0.000541419	0.02021630885528687
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000541419	0.02021630885528687
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.02021630885528687
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.02021630885528687
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.02021630885528687
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.02021630885528687
STT3B-CDG	0.000541419	0.02021630885528687
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.02021630885528687
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.02021630885528687
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.02021630885528687
RAMON SYNDROME	0.000541419	0.02021630885528687
CLASSIC HOMOCYSTINURIA	0.000541419	0.02021630885528687
SSR4-CDG	0.000541419	0.02021630885528687
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000541419	0.02021630885528687
MONOSOMY 22Q13.3	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.000541419	0.02021630885528687
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000541419	0.02021630885528687
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.02021630885528687
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.02021630885528687
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED 90	0.000541419	0.02021630885528687
HYPOPHOSPHATASIA	0.000541419	0.02021630885528687
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.02021630885528687
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED 88	0.000541419	0.02021630885528687
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.02021630885528687
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.02021630885528687
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.000541419	0.02021630885528687
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000541419	0.02021630885528687
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000541419	0.02021630885528687
ADRENOLEUKODYSTROPHY	0.000541419	0.02021630885528687
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.02021630885528687
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.02021630885528687
XYLOSIDASE DEFICIENCY	0.000541419	0.02021630885528687
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02021630885528687
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.02021630885528687
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000541419	0.02021630885528687
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.02021630885528687
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.02021630885528687
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000541419	0.02021630885528687
ATKIN-FLAITZ SYNDROME	0.000541419	0.02021630885528687
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000541419	0.02021630885528687
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.02021630885528687
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.000541419	0.02021630885528687
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000541419	0.02021630885528687
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000541419	0.02021630885528687
CLARK-BARAITSER SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED 72	0.000541419	0.02021630885528687
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.02021630885528687
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.02021630885528687
PHACE SYNDROME	0.000541419	0.02021630885528687
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000541419	0.02021630885528687
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.02021630885528687
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.02021630885528687
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.000541419	0.02021630885528687
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.02021630885528687
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000541419	0.02021630885528687
THREONINEMIA	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.02021630885528687
TAY-SACHS DISEASE; TSD	0.000541419	0.02021630885528687
SHUKLA-VERNON SYNDROME; SHUVER	0.000541419	0.02021630885528687
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000541419	0.02021630885528687
XQ25 DUPLICATION SYNDROME	0.000541419	0.02021630885528687
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.000541419	0.02021630885528687
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000541419	0.02021630885528687
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.02021630885528687
FILIPPI SYNDROME; FLPIS	0.000541419	0.02021630885528687
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.02021630885528687
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000541419	0.02021630885528687
MEND SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED 103	0.000541419	0.02021630885528687
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000541419	0.02021630885528687
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.02021630885528687
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.000541419	0.02021630885528687
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.02021630885528687
MALAN OVERGROWTH SYNDROME	0.000541419	0.02021630885528687
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.02021630885528687
HYPERPROLINEMIA TYPE 1	0.000541419	0.02021630885528687
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.02021630885528687
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.000541419	0.02021630885528687
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.02021630885528687
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.02021630885528687
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.02021630885528687
MEND SYNDROME; MEND	0.000541419	0.02021630885528687
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000541419	0.02021630885528687
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000541419	0.02021630885528687
IMMUNODEFICIENCY 47	0.000541419	0.02021630885528687
9Q33.3Q34.11 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.02021630885528687
PHENYLKETONURIA	0.000541419	0.02021630885528687
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.02021630885528687
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000541419	0.02021630885528687
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.02021630885528687
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.02021630885528687
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.02021630885528687
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.02021630885528687
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.02021630885528687
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000541419	0.02021630885528687
DIGEORGE SYNDROME; DGS	0.000541419	0.02021630885528687
STURGE-WEBER SYNDROME	0.000541419	0.02021630885528687
DPAGT1-CDG	0.000541419	0.02021630885528687
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.02021630885528687
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000541419	0.02021630885528687
PRADER-WILLI SYNDROME; PWS	0.000541419	0.02021630885528687
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.02021630885528687
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.02021630885528687
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.02021630885528687
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.02021630885528687
WALKER-WARBURG SYNDROME	0.000541419	0.02021630885528687
PARIETAL FORAMINA	0.000541419	0.02021630885528687
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.02021630885528687
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.02021630885528687
HEREDITARY FOLATE MALABSORPTION	0.000541419	0.02021630885528687
SYSTEMIC SCLEROSIS	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000541419	0.02021630885528687
FETAL GAUCHER DISEASE	0.000541419	0.02021630885528687
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.02021630885528687
MOGS-CDG	0.000541419	0.02021630885528687
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.02021630885528687
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.02021630885528687
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.02021630885528687
PORPHYRIA VARIEGATA	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.02021630885528687
GRISCELLI SYNDROME TYPE 2	0.000541419	0.02021630885528687
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.02021630885528687
C SYNDROME	0.000541419	0.02021630885528687
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.02021630885528687
47,XYY SYNDROME	0.000541419	0.02021630885528687
SCLERODERMA	0.000541419	0.02021630885528687
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.02021630885528687
SECKEL SYNDROME 1; SCKL1	0.000541419	0.02021630885528687
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000541419	0.02021630885528687
KEUTEL SYNDROME	0.000541419	0.02021630885528687
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000541419	0.02021630885528687
SMITH-LEMLI-OPITZ SYNDROME	0.000541419	0.02021630885528687
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.02021630885528687
ISOLATED SPINA BIFIDA	0.000541419	0.02021630885528687
SCRUB TYPHUS	0.000541419	0.02021630885528687
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.02021630885528687
ENCEPHALITIS LETHARGICA	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.02021630885528687
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.000541419	0.02021630885528687
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000541419	0.02021630885528687
ADDISON DISEASE	0.000541419	0.02021630885528687
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.02021630885528687
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.02021630885528687
GENITOPATELLAR SYNDROME	0.000541419	0.02021630885528687
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000541419	0.02021630885528687
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.02021630885528687
DPM1-CDG	0.000541419	0.02021630885528687
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.02021630885528687
CROUZON SYNDROME	0.000541419	0.02021630885528687
ADRENOMYODYSTROPHY	0.000541419	0.02021630885528687
DARIER-WHITE DISEASE; DAR	0.000541419	0.02021630885528687
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.02021630885528687
BOHRING-OPITZ SYNDROME	0.000541419	0.02021630885528687
INSULINOMA	0.000541419	0.02021630885528687
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.02021630885528687
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.02021630885528687
49,XXXXY SYNDROME	0.000541419	0.02021630885528687
48,XXXY SYNDROME	0.000541419	0.02021630885528687
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.02021630885528687
COFFIN-SIRIS SYNDROME 1; CSS1	0.000541419	0.02021630885528687
EMANUEL SYNDROME	0.000541419	0.02021630885528687
RECOMBINANT 8 SYNDROME	0.000541419	0.02021630885528687
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.02021630885528687
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.02021630885528687
PAPILLORENAL SYNDROME	0.000541419	0.02021630885528687
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.02021630885528687
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.000541419	0.02021630885528687
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.02021630885528687
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.02021630885528687
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.02021630885528687
ADAMS-OLIVER SYNDROME 1; AOS1	0.000541419	0.02021630885528687
15Q13.3 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
2Q33.1 DELETION SYNDROME	0.000541419	0.02021630885528687
HADDAD SYNDROME	0.000541419	0.02021630885528687
LASSA FEVER	0.000541419	0.02021630885528687
XQ28 (MECP2) DUPLICATION	0.000541419	0.02021630885528687
SECONDARY SYRINGOMYELIA	0.000541419	0.02021630885528687
POTOCKI-SHAFFER SYNDROME	0.000541419	0.02021630885528687
1P36 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
NON-DISTAL MONOSOMY 20Q	0.000541419	0.02021630885528687
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.02021630885528687
DISTAL MONOSOMY 19P13.3	0.000541419	0.02021630885528687
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.02021630885528687
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.02021630885528687
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.02021630885528687
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.02021630885528687
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.02021630885528687
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.02021630885528687
PFEIFFER SYNDROME TYPE 2	0.000541419	0.02021630885528687
PFEIFFER SYNDROME TYPE 3	0.000541419	0.02021630885528687
HOLOPROSENCEPHALY 2; HPE2	0.000541419	0.02021630885528687
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.02021630885528687
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.02021630885528687
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000541419	0.02021630885528687
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.02021630885528687
FG SYNDROME TYPE 1	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.02021630885528687
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.02021630885528687
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.02021630885528687
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.02021630885528687
15Q24 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.02021630885528687
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.02021630885528687
KBG SYNDROME	0.000541419	0.02021630885528687
KABUKI SYNDROME 1	0.000541419	0.02021630885528687
PALLISTER-HALL SYNDROME	0.000541419	0.02021630885528687
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.02021630885528687
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.02021630885528687
HUNTINGTON DISEASE; HD	0.000541419	0.02021630885528687
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.02021630885528687
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.02021630885528687
PITUITARY STALK INTERRUPTION SYNDROME	0.000541419	0.02021630885528687
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.02021630885528687
ALG1-CDG	0.000541419	0.02021630885528687
ALG3-CDG	0.000541419	0.02021630885528687
PETERS-PLUS SYNDROME; PTRPLS	0.000541419	0.02021630885528687
LANDAU-KLEFFNER SYNDROME	0.000541419	0.02021630885528687
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000541419	0.02021630885528687
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.02021630885528687
KAPUR-TORIELLO SYNDROME	0.000541419	0.02021630885528687
KETOADIPICACIDURIA	0.000541419	0.02021630885528687
KEUTEL SYNDROME; KTLS	0.000541419	0.02021630885528687
KIFAFA SEIZURE DISORDER	0.000541419	0.02021630885528687
22Q11.2 DELETION SYNDROME	0.000541419	0.02021630885528687
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.02021630885528687
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.02021630885528687
MACDERMOT-WINTER SYNDROME	0.000541419	0.02021630885528687
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000541419	0.02021630885528687
CRANIOPHARYNGIOMA	0.000541419	0.02021630885528687
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.02021630885528687
MARDEN-WALKER SYNDROME	0.000541419	0.02021630885528687
VICI SYNDROME; VICIS	0.000541419	0.02021630885528687
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.02021630885528687
CENTRONUCLEAR MYOPATHY	0.000541419	0.02021630885528687
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.02021630885528687
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.02021630885528687
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000541419	0.02021630885528687
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.02021630885528687
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.02021630885528687
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.02021630885528687
NETHERTON SYNDROME	0.000541419	0.02021630885528687
ALSTRÖM SYNDROME	0.000541419	0.02021630885528687
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.02021630885528687
NARP SYNDROME	0.000541419	0.02021630885528687
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.02021630885528687
RECURRENT ACUTE PANCREATITIS	0.000541419	0.02021630885528687
NEVUS COMEDONICUS SYNDROME	0.000541419	0.02021630885528687
HYPERPROLINEMIA, TYPE II	0.000541419	0.02021630885528687
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
LIPOID PROTEINOSIS	0.000541419	0.02021630885528687
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000541419	0.02021630885528687
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.02021630885528687
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.02021630885528687
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.02021630885528687
16P13.2 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02021630885528687
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.02021630885528687
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.000541419	0.02021630885528687
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.02021630885528687
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.02021630885528687
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.02021630885528687
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.02021630885528687
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.02021630885528687
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.02021630885528687
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.02021630885528687
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.02021630885528687
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.02021630885528687
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.02021630885528687
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.02021630885528687
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000541419	0.02021630885528687
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.02021630885528687
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000541419	0.02021630885528687
XQ25 MICRODUPLICATION SYNDROME	0.000541419	0.02021630885528687
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000541419	0.02021630885528687
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.000541419	0.02021630885528687
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.02021630885528687
OHDO SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.02021630885528687
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.02021630885528687
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.02021630885528687
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.02021630885528687
LEBER CONGENITAL AMAUROSIS	0.000541419	0.02021630885528687
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.02021630885528687
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.02021630885528687
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.02021630885528687
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.02021630885528687
TEMTAMY SYNDROME; TEMTYS	0.000541419	0.02021630885528687
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.02021630885528687
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.02021630885528687
RUBINSTEIN-TAYBI SYNDROME	0.000541419	0.02021630885528687
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.02021630885528687
CROME SYNDROME	0.000541419	0.02021630885528687
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000541419	0.02021630885528687
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.02021630885528687
MONOSOMY 9Q22.3	0.000541419	0.02021630885528687
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000541419	0.02021630885528687
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.02021630885528687
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.02021630885528687
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.02021630885528687
COHEN SYNDROME	0.000541419	0.02021630885528687
DEND SYNDROME	0.000541419	0.02021630885528687
EPISODIC ATAXIA TYPE 3	0.000541419	0.02021630885528687
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000541419	0.02021630885528687
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.02021630885528687
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.02021630885528687
CLASSIC PHENYLKETONURIA	0.000541419	0.02021630885528687
GRISCELLI SYNDROME, TYPE 1	0.000541419	0.02021630885528687
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000541419	0.02021630885528687
HEREDITARY COPROPORPHYRIA	0.000541419	0.02021630885528687
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.02021630885528687
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000541419	0.02021630885528687
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.02021630885528687
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000541419	0.02021630885528687
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.02021630885528687
RABIES	0.000541419	0.02021630885528687
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.02021630885528687
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.02021630885528687
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000541419	0.02021630885528687
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.02021630885528687
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.02021630885528687
HYPER-BETA-ALANINEMIA	0.000541419	0.02021630885528687
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000541419	0.02021630885528687
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000541419	0.02021630885528687
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000541419	0.02021630885528687
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000541419	0.02021630885528687
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000541419	0.02021630885528687
HOLOPROSENCEPHALY 1; HPE1	0.000541419	0.02021630885528687
MOWAT-WILSON SYNDROME; MOWS	0.000541419	0.02021630885528687
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.02021630885528687
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.02021630885528687
HARTNUP DISORDER	0.000541419	0.02021630885528687
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000541419	0.02021630885528687
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.02021630885528687
6Q TERMINAL DELETION SYNDROME	0.000541419	0.02021630885528687
BERNARD-SOULIER SYNDROME	0.000541419	0.02021630885528687
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.02021630885528687
GAUCHER DISEASE, TYPE II	0.000541419	0.02021630885528687
FRYNS SYNDROME; FRNS	0.000541419	0.02021630885528687
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.02021630885528687
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.02021630885528687
FOUNTAIN SYNDROME	0.000541419	0.02021630885528687
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.02021630885528687
EPILEPSY-TELANGIECTASIA	0.000541419	0.02021630885528687
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000541419	0.02021630885528687
PORPHYRIA	0.000541419	0.02021630885528687
PRADER-WILLI SYNDROME	0.000541419	0.02021630885528687
PROTEUS SYNDROME	0.000541419	0.02021630885528687
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.02021630885528687
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.02021630885528687
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.02021630885528687
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.02021630885528687
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000541419	0.02021630885528687
FRONTAL ENCEPHALOCELE	0.000541419	0.02021630885528687
TENORIO SYNDROME; TNORS	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.000541419	0.02021630885528687
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.02021630885528687
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000541419	0.02021630885528687
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.02021630885528687
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000541419	0.02021630885528687
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000541419	0.02021630885528687
ACROMELIC FRONTONASAL DYSPLASIA	0.000541419	0.02021630885528687
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000541419	0.02021630885528687
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000541419	0.02021630885528687
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000541419	0.02021630885528687
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000541419	0.02021630885528687
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.02021630885528687
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.02021630885528687
ACROCARDIOFACIAL SYNDROME	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.02021630885528687
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.02021630885528687
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.02021630885528687
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.02021630885528687
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.02021630885528687
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.02021630885528687
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.02021630885528687
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.02021630885528687
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000541419	0.02021630885528687
CATEL-MANZKE SYNDROME; CATMANS	0.000541419	0.02021630885528687
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000541419	0.02021630885528687
CENTRAL DIABETES INSIPIDUS	0.000541419	0.02021630885528687
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000541419	0.02021630885528687
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02021630885528687
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000541419	0.02021630885528687
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000541419	0.02021630885528687
WOLCOTT-RALLISON SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000541419	0.02021630885528687
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000541419	0.02021630885528687
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.000541419	0.02021630885528687
COFFIN-SIRIS SYNDROME 5	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000541419	0.02021630885528687
2P21 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
DISTAL MONOSOMY 7Q36	0.000541419	0.02021630885528687
2Q24 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.000541419	0.02021630885528687
MONOSOMY 18Q	0.000541419	0.02021630885528687
LUSCAN-LUMISH SYNDROME; LLS	0.000541419	0.02021630885528687
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.000541419	0.02021630885528687
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000541419	0.02021630885528687
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.02021630885528687
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000541419	0.02021630885528687
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.02021630885528687
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.02021630885528687
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.02021630885528687
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.02021630885528687
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000541419	0.02021630885528687
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.02021630885528687
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.02021630885528687
DESANTO-SHINAWI SYNDROME	0.000541419	0.02021630885528687
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000541419	0.02021630885528687
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.02021630885528687
DISTAL TRISOMY 15Q	0.000541419	0.02021630885528687
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000541419	0.02021630885528687
MOSAIC TRISOMY 14	0.000541419	0.02021630885528687
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000541419	0.02021630885528687
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.02021630885528687
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000541419	0.02021630885528687
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.02021630885528687
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.02021630885528687
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.02021630885528687
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000541419	0.02021630885528687
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.02021630885528687
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.02021630885528687
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.02021630885528687
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.02021630885528687
INFANTILE LIVER FAILURE SYNDROME 1	0.000541419	0.02021630885528687
NEPHROGENIC DIABETES INSIPIDUS	0.000541419	0.02021630885528687
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.02021630885528687
MATERNAL PHENYLKETONURIA	0.000541419	0.02021630885528687
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000541419	0.02021630885528687
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.02021630885528687
SCHAAF-YANG SYNDROME; SHFYNG	0.000541419	0.02021630885528687
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.02021630885528687
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.02021630885528687
COWDEN SYNDROME 5; CWS5	0.000541419	0.02021630885528687
DUANE RETRACTION SYNDROME	0.000541419	0.02021630885528687
COWDEN SYNDROME 6; CWS6	0.000541419	0.02021630885528687
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.02021630885528687
SANJAD-SAKATI SYNDROME	0.000541419	0.02021630885528687
LISSENCEPHALY 5; LIS5	0.000541419	0.02021630885528687
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000541419	0.02021630885528687
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.02021630885528687
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000541419	0.02021630885528687
JACOBSEN SYNDROME	0.000541419	0.02021630885528687
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.02021630885528687
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.02021630885528687
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.02021630885528687
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.02021630885528687
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.02021630885528687
CONGENITAL HYDROCEPHALUS	0.000541419	0.02021630885528687
HYDRANENCEPHALY	0.000541419	0.02021630885528687
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.02021630885528687
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000541419	0.02021630885528687
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000541419	0.02021630885528687
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000541419	0.02021630885528687
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000541419	0.02021630885528687
HELSMOORTEL-VAN DER AA SYNDROME	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.02021630885528687
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.02021630885528687
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.02021630885528687
WEBB-DATTANI SYNDROME; WEDAS	0.000541419	0.02021630885528687
FRYNS SYNDROME	0.000541419	0.02021630885528687
CRIGLER-NAJJAR SYNDROME	0.000541419	0.02021630885528687
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.02021630885528687
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000541419	0.02021630885528687
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.02021630885528687
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.02021630885528687
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.02021630885528687
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000541419	0.02021630885528687
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000541419	0.02021630885528687
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000541419	0.02021630885528687
CHROMOSOME 5Q12 DELETION SYNDROME	0.000541419	0.02021630885528687
MOWAT-WILSON SYNDROME	0.000541419	0.02021630885528687
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.02021630885528687
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.02021630885528687
DONNAI-BARROW SYNDROME	0.000541419	0.02021630885528687
HENNEKAM SYNDROME	0.000541419	0.02021630885528687
HENNEKAM-BEEMER SYNDROME	0.000541419	0.02021630885528687
CYSTATHIONINURIA	0.000541419	0.02021630885528687
HARROD SYNDROME	0.000541419	0.02021630885528687
HALL-RIGGS SYNDROME	0.000541419	0.02021630885528687
DISTAL MONOSOMY 15Q	0.000541419	0.02021630885528687
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.02021630885528687
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.02021630885528687
2Q37 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000541419	0.02021630885528687
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000541419	0.02021630885528687
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.02021630885528687
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.02021630885528687
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.02021630885528687
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000541419	0.02021630885528687
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.02021630885528687
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000541419	0.02021630885528687
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.02021630885528687
JABERI-ELAHI SYNDROME; JABELS	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000541419	0.02021630885528687
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.02021630885528687
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000541419	0.02021630885528687
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000541419	0.02021630885528687
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000541419	0.02021630885528687
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.02021630885528687
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000541419	0.02021630885528687
KLEEFSTRA SYNDROME 2; KLEFS2	0.000541419	0.02021630885528687
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000541419	0.02021630885528687
ROMANO-WARD SYNDROME	0.000541419	0.02021630885528687
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.02021630885528687
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.02021630885528687
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.02021630885528687
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000541419	0.02021630885528687
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.02021630885528687
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000541419	0.02021630885528687
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000541419	0.02021630885528687
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000541419	0.02021630885528687
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.02021630885528687
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000541419	0.02021630885528687
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.02021630885528687
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.02021630885528687
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000541419	0.02021630885528687
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.02021630885528687
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000541419	0.02021630885528687
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.02021630885528687
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.02021630885528687
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000541419	0.02021630885528687
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000541419	0.02021630885528687
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000541419	0.02021630885528687
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000541419	0.02021630885528687
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.000541419	0.02021630885528687
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000541419	0.02021630885528687
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.000541419	0.02021630885528687
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.02021630885528687
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000541419	0.02021630885528687
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.02021630885528687
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.02021630885528687
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000541419	0.02021630885528687
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000541419	0.02021630885528687
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.02021630885528687
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000541419	0.02021630885528687
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000541419	0.02021630885528687
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.02021630885528687
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000541419	0.02021630885528687
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000541419	0.02021630885528687
ROSAÏ-DORFMAN DISEASE	0.000541419	0.02021630885528687
COFFIN-SIRIS SYNDROME	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000541419	0.02021630885528687
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.02021630885528687
RING CHROMOSOME 10 SYNDROME	0.000541419	0.02021630885528687
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000541419	0.02021630885528687
XQ21 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.02021630885528687
SHASHI-PENA SYNDROME; SHAPNS	0.000541419	0.02021630885528687
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000541419	0.02021630885528687
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000541419	0.02021630885528687
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.02021630885528687
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.02021630885528687
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000541419	0.02021630885528687
17Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.02021630885528687
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000541419	0.02021630885528687
IMMUNODEFICIENCY 49; IMD49	0.000541419	0.02021630885528687
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000541419	0.02021630885528687
COFS SYNDROME	0.000541419	0.02021630885528687
LISSENCEPHALY 8; LIS8	0.000541419	0.02021630885528687
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.02021630885528687
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.02021630885528687
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.02021630885528687
MIRAGE SYNDROME; MIRAGE	0.000541419	0.02021630885528687
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.02021630885528687
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000541419	0.02021630885528687
KNOBLOCH SYNDROME	0.000541419	0.02021630885528687
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.02021630885528687
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000541419	0.02021630885528687
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.02021630885528687
CRYPTOCOCCOSIS	0.000541419	0.02021630885528687
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.02021630885528687
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.02021630885528687
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.02021630885528687
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.02021630885528687
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.02021630885528687
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.02021630885528687
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.02021630885528687
AL KAISSI SYNDROME; ALKAS	0.000541419	0.02021630885528687
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.02021630885528687
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000541419	0.02021630885528687
BOWEN-CONRADI SYNDROME	0.000541419	0.02021630885528687
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.02021630885528687
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000541419	0.02021630885528687
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000541419	0.02021630885528687
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.02021630885528687
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.02021630885528687
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.02021630885528687
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000541419	0.02021630885528687
BETA-MANNOSIDOSIS	0.000541419	0.02021630885528687
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000541419	0.02021630885528687
JOUBERT SYNDROME 30; JBTS30	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000541419	0.02021630885528687
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000541419	0.02021630885528687
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000541419	0.02021630885528687
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000541419	0.02021630885528687
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.02021630885528687
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000541419	0.02021630885528687
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION	0.000541419	0.02021630885528687
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.000541419	0.02021630885528687
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000541419	0.02021630885528687
PSEUDO-TORCH SYNDROME 2	0.000541419	0.02021630885528687
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.02021630885528687
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000541419	0.02021630885528687
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.02021630885528687
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.02021630885528687
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000541419	0.02021630885528687
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.000541419	0.02021630885528687
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.02021630885528687
C SYNDROME	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.000541419	0.02021630885528687
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.000541419	0.02021630885528687
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.02021630885528687
EBOLA HEMORRHAGIC FEVER	0.000541419	0.02021630885528687
WIEDEMANN-STEINER SYNDROME	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000541419	0.02021630885528687
GAUCHER DISEASE, PERINATAL LETHAL	0.000541419	0.02021630885528687
SIALURIA	0.000541419	0.02021630885528687
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.000541419	0.02021630885528687
KAGAMI-OGATA SYNDROME	0.000541419	0.02021630885528687
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.02021630885528687
15Q OVERGROWTH SYNDROME	0.000541419	0.02021630885528687
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000541419	0.02021630885528687
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.02021630885528687
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.000541419	0.02021630885528687
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000541419	0.02021630885528687
LUJO HEMORRHAGIC FEVER	0.000541419	0.02021630885528687
RIFT VALLEY FEVER	0.000541419	0.02021630885528687
NOCARDIOSIS	0.000541419	0.02021630885528687
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.02021630885528687
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.02021630885528687
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000541419	0.02021630885528687
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.02021630885528687
RENPENNING SYNDROME	0.000541419	0.02021630885528687
PROPIONIC ACIDEMIA	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000541419	0.02021630885528687
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000541419	0.02021630885528687
PHACE ASSOCIATION	0.000541419	0.02021630885528687
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000541419	0.02021630885528687
LATHOSTEROLOSIS	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000541419	0.02021630885528687
LISSENCEPHALY 1; LIS1	0.000541419	0.02021630885528687
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.02021630885528687
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000541419	0.02021630885528687
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000541419	0.02021630885528687
RUVALCABA SYNDROME	0.000541419	0.02021630885528687
EMANUEL SYNDROME	0.000541419	0.02021630885528687
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.02021630885528687
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000541419	0.02021630885528687
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000541419	0.02021630885528687
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.02021630885528687
11P15.4 MICRODUPLICATION SYNDROME	0.000541419	0.02021630885528687
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.000541419	0.02021630885528687
KLEEFSTRA SYNDROME	0.000541419	0.02021630885528687
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.02021630885528687
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.02021630885528687
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.02021630885528687
PROLACTINOMA	0.000541419	0.02021630885528687
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.02021630885528687
PORENCEPHALY	0.000541419	0.02021630885528687
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000541419	0.02021630885528687
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.02021630885528687
CHROMOSOME 16P13.3 DELETION SYNDROME	0.000541419	0.02021630885528687
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.02021630885528687
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000541419	0.02021630885528687
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.02021630885528687
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.02021630885528687
RAMON SYNDROME	0.000541419	0.02021630885528687
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.02021630885528687
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.02021630885528687
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.02021630885528687
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.02021630885528687
CHROMOSOME 10Q26 DELETION SYNDROME	0.000541419	0.02021630885528687
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000541419	0.02021630885528687
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.02021630885528687
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000541419	0.02021630885528687
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.000541419	0.02021630885528687
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000541419	0.02021630885528687
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.02021630885528687
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.02021630885528687
ISOLATED BILIARY ATRESIA	0.000541419	0.02021630885528687
BOHRING-OPITZ SYNDROME	0.000541419	0.02021630885528687
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.02021630885528687
CRONKHITE-CANADA SYNDROME	0.000541419	0.02021630885528687
19P13.13 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.02021630885528687
CHROMOSOME 2Q37 DELETION SYNDROME	0.000541419	0.02021630885528687
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.02021630885528687
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000541419	0.02021630885528687
TIMOTHY SYNDROME; TS	0.000541419	0.02021630885528687
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000541419	0.02021630885528687
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.000541419	0.02021630885528687
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.000541419	0.02021630885528687
GURRIERI SYNDROME	0.000541419	0.02021630885528687
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.02021630885528687
POTOCKI-SHAFFER SYNDROME	0.000541419	0.02021630885528687
GALACTOSIALIDOSIS	0.000541419	0.02021630885528687
FUCOSIDOSIS	0.000541419	0.02021630885528687
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.02021630885528687
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.02021630885528687
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.02021630885528687
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.02021630885528687
CODAS SYNDROME	0.000541419	0.02021630885528687
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000541419	0.02021630885528687
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000541419	0.02021630885528687
WIEACKER-WOLFF SYNDROME	0.000541419	0.02021630885528687
DISTAL MONOSOMY 1Q	0.000541419	0.02021630885528687
20Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.02021630885528687
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.02021630885528687
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.02021630885528687
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.000541419	0.02021630885528687
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000541419	0.02021630885528687
OCULOECTODERMAL SYNDROME; OES	0.000541419	0.02021630885528687
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.02021630885528687
GLIOBLASTOMA	0.000541419	0.02021630885528687
BAND HETEROTOPIA; BH	0.000541419	0.02021630885528687
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.02021630885528687
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000541419	0.02021630885528687
CHIME SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.02021630885528687
CRANIOSYNOSTOSIS 2	0.000541419	0.02021630885528687
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.02021630885528687
TETRASOMY 9P	0.000541419	0.02021630885528687
TETRASOMY 5P	0.000541419	0.02021630885528687
TETRASOMY 18P	0.000541419	0.02021630885528687
DUPLICATION/INVERSION 15Q11	0.000541419	0.02021630885528687
MERCURY POISONING	0.000541419	0.02021630885528687
ISOVALERIC ACIDEMIA	0.000541419	0.02021630885528687
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.02021630885528687
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000541419	0.02021630885528687
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000541419	0.02021630885528687
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.02021630885528687
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.02021630885528687
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.02021630885528687
FILIPPI SYNDROME	0.000541419	0.02021630885528687
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.02021630885528687
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.02021630885528687
MUENKE SYNDROME	0.000541419	0.02021630885528687
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000541419	0.02021630885528687
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000541419	0.02021630885528687
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.02021630885528687
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.02021630885528687
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000541419	0.02021630885528687
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000541419	0.02021630885528687
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.02021630885528687
PALLISTER-KILLIAN SYNDROME	0.000541419	0.02021630885528687
CHROMOSOME 18Q DELETION SYNDROME	0.000541419	0.02021630885528687
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.02021630885528687
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.02021630885528687
VIRAL HEMORRHAGIC FEVER	0.000541419	0.02021630885528687
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.02021630885528687
DISTAL TRISOMY 17Q	0.000541419	0.02021630885528687
PIERPONT SYNDROME	0.000541419	0.02021630885528687
GRACILE BONE DYSPLASIA; GCLEB	0.000541419	0.02021630885528687
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.02021630885528687
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.02021630885528687
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.02021630885528687
DUBOWITZ SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000541419	0.02021630885528687
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.02021630885528687
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.02021630885528687
KAGAMI-OGATA SYNDROME	0.000541419	0.02021630885528687
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
19P13.12 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.02021630885528687
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000541419	0.02021630885528687
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.02021630885528687
PINEOBLASTOMA	0.000541419	0.02021630885528687
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000541419	0.02021630885528687
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.02021630885528687
SUBEPENDYMOMA	0.000541419	0.02021630885528687
EPENDYMOMA	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000541419	0.02021630885528687
MICROSPORIDIOSIS	0.000541419	0.02021630885528687
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.02021630885528687
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.02021630885528687
ADAMS-OLIVER SYNDROME 2; AOS2	0.000541419	0.02021630885528687
15Q14 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000541419	0.02021630885528687
MONOSOMY 9P	0.000541419	0.02021630885528687
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000541419	0.02021630885528687
PERRAULT SYNDROME 3	0.000541419	0.02021630885528687
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.000541419	0.02021630885528687
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.02021630885528687
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.02021630885528687
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.02021630885528687
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.02021630885528687
MOYNAHAN SYNDROME	0.000541419	0.02021630885528687
MOYAMOYA DISEASE	0.000541419	0.02021630885528687
MOMO SYNDROME	0.000541419	0.02021630885528687
CK SYNDROME	0.000541419	0.02021630885528687
COFFIN-SIRIS SYNDROME 2; CSS2	0.000541419	0.02021630885528687
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000541419	0.02021630885528687
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000541419	0.02021630885528687
SECKEL SYNDROME 7; SCKL7	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.02021630885528687
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.02021630885528687
LOWRY-MACLEAN SYNDROME	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.02021630885528687
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.02021630885528687
4Q21 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000541419	0.02021630885528687
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.02021630885528687
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.02021630885528687
CITRULLINEMIA TYPE II	0.000541419	0.02021630885528687
8P11.2 DELETION SYNDROME	0.000541419	0.02021630885528687
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.02021630885528687
6Q25 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
3Q29 MICRODUPLICATION SYNDROME	0.000541419	0.02021630885528687
2Q31.1 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
COFFIN-SIRIS SYNDROME 3; CSS3	0.000541419	0.02021630885528687
COFFIN-SIRIS SYNDROME 4; CSS4	0.000541419	0.02021630885528687
MICRO SYNDROME	0.000541419	0.02021630885528687
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
1Q21.1 MICRODUPLICATION SYNDROME	0.000541419	0.02021630885528687
1Q21.1 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
AICA-RIBOSIDURIA	0.000541419	0.02021630885528687
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.02021630885528687
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000541419	0.02021630885528687
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000541419	0.02021630885528687
PONTINE TEGMENTAL CAP DYSPLASIA	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000541419	0.02021630885528687
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000541419	0.02021630885528687
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
HOLOPROSENCEPHALY 7	0.000541419	0.02021630885528687
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000541419	0.02021630885528687
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000541419	0.02021630885528687
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.000541419	0.02021630885528687
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.02021630885528687
GLASS SYNDROME	0.000541419	0.02021630885528687
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000541419	0.02021630885528687
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.02021630885528687
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.02021630885528687
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000541419	0.02021630885528687
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02021630885528687
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000541419	0.02021630885528687
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.02021630885528687
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.02021630885528687
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.02021630885528687
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.000541419	0.02021630885528687
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.02021630885528687
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.000541419	0.02021630885528687
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000541419	0.02021630885528687
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
PITT-HOPKINS SYNDROME	0.000541419	0.02021630885528687
PITT-HOPKINS SYNDROME	0.000541419	0.02021630885528687
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000541419	0.02021630885528687
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000541419	0.02021630885528687
TARP SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.02021630885528687
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.02021630885528687
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.02021630885528687
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000541419	0.02021630885528687
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.02021630885528687
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000541419	0.02021630885528687
XP22.13P22.2 DUPLICATION SYNDROME	0.000541419	0.02021630885528687
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000541419	0.02021630885528687
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.02021630885528687
611961 STEVENSON-CAREY SYNDROME	0.000541419	0.02021630885528687
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.000541419	0.02021630885528687
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000541419	0.02021630885528687
COG5-CDG	0.000541419	0.02021630885528687
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.02021630885528687
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.02021630885528687
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.000541419	0.02021630885528687
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000541419	0.02021630885528687
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000541419	0.02021630885528687
XP21 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.02021630885528687
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
LISSENCEPHALY 4	0.000541419	0.02021630885528687
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000541419	0.02021630885528687
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
20P12.3 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.02021630885528687
17Q12 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.02021630885528687
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000541419	0.02021630885528687
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000541419	0.02021630885528687
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.000541419	0.02021630885528687
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000541419	0.02021630885528687
L1 SYNDROME	0.000541419	0.02021630885528687
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.02021630885528687
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.02021630885528687
GABA-TRANSAMINASE DEFICIENCY	0.000541419	0.02021630885528687
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000541419	0.02021630885528687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.02021630885528687
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.02021630885528687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.02021630885528687
CHROMOSOME 19P13.13 DELETION SYNDROME	0.000541419	0.02021630885528687
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.02021630885528687
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.02021630885528687
THANATOPHORIC DYSPLASIA	0.000541419	0.02021630885528687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000541419	0.02021630885528687
TRISOMY 8P	0.000541419	0.02021630885528687
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.02021630885528687
